Legal status in Solomon Islands

Per-substance legal status for Solomon Islands, from sourced statutes where available. Legal information, not legal advice; drug laws change, so confirm with the destination’s embassy or drug authority before you travel.

24 confirmed substances64 not individually verifiedLast updated October 7, 2026

Confirmed legal status

Adderall

Legal status: Controlled. That applies to a product that contains amphetamine or dexamphetamine. The instruments read do not use the brand name Adderall; they name 'Amphetamine', 'Dexamphetamine' and 'Dexedrine'. The identity comes from a chemical record and is not stated in any law read: the DailyMed label for one Adderall tablet product (US National Library of Medicine) describes 'A single-entity amphetamine product combining the neutral sulfate salts of dextroamphetamine and amphetamine, with the dextro isomer of amphetamine saccharate and d, l-amphetamine aspartate'; that is one label, and whether every product sold under the name has that composition is not stated by any instrument read, so the verdict applies to a product that contains amphetamine or dexamphetamine, whatever name it is sold under. The Dangerous Drugs Act (Cap. 98, reprint as in force at 1 October 2009) Part III is applied under section 13(2) by the proclamation of 21 September 1987 (LN 101 of 1987), printed pages 2821 to 2823, whose paragraph 1 lists 'Amphetamine', 'Dexamphetamine' and 'Dexedrine' on page 2821. A salt of either is within paragraph 4, 'Any salt of a substance specified in any of paragraphs 1 to 3', and a tablet or capsule is within paragraph 5, 'Any preparations or other product containing a substance of product specified in any of paragraphs 1 to 4, not being a preparation specified in Schedule 1'. No Schedule 1 appears in the pages read, so which preparations stand outside the control is not established. LN 6 of 1988 paragraphs (d) and (h) (printed page 2824) refer instead to 'the Schedule to the Proclamation referred to in paragraph (a)', so 'Schedule 1' in LN 101 paragraphs 5 and 9 may mean the paragraph 1 list of that Schedule; no instrument read states that reading. The second list in paragraph 6 on printed page 2823 prints 'Dexamphetamine' and, where 'Amphetamine' should be, the word 'Amohetamine', an apparent printing error on that page; paragraph (e) of LN 6 of 1988 on printed page 2824 prints 'Amphetamine' and 'Dexamphetamine'. The verdict rests on paragraph 1 and paragraph (e). The margin of printed page 2824 reads LN 61/1988, while the heading on page 2821 and the 2025 Rules cite LN 6 of 1988. The named entries govern. Schedule B Part I of the Pharmacy and Poisons Act also lists 'Amphetamines' as a poison, a sale restriction separate from drug control.
Consequences if caught: Adderall, as a preparation of amphetamine salts within Part III: Part III drugs carry these provisions. Personal possession: section 20 makes it an offence against the Act where a Part III drug is found in a person's possession or kept in any place other than the appointed store, unless he can prove that it was obtained under the authority of the Act, or in accordance with the prescription of a registered medical practitioner, or from a person having authority to sell it, or was deposited there without his knowledge or consent. The burden of proof is on the accused, and the section sets no quantity threshold. Possession for supply, sale and trafficking: the Act's text states no separate offence for these for Part III drugs. Sale and distribution are left to rules the Minister may make under section 15(1)(b), and the only rules located are the 2025 methylamphetamine rules, so for this substance a sale offence is not verified beyond the general offence in section 39(1)(a) of contravening the Act or a rule under it. Import and export: sections 14, 23, 25, 28 and 30 prohibit them except in accordance with sections 22 to 30, and section 3 limits entry and exit to a port approved by notice; a person exporting in contravention is also liable under section 35(2) to forfeit treble the value of the goods or 2,000 penalty units at the option of the Comptroller of Customs and Excise. Manufacture: section 15(1)(a) lets rules prohibit manufacture except on licensed premises, and no manufacture offence is stated in the Act's text itself. Cultivation: not applicable to a synthetic or manufactured substance. Use or consumption: the instruments read state no separate offence of use for Part III drugs, so possession under section 20 is the exposure. Administrative offences: section 39(1)(b) and (c) cover breach of licence conditions and false statements to obtain a licence. Penalty: no penalty is otherwise prescribed, so section 39(2) applies to each offence, namely on conviction by the court sitting with assessors a fine of 100,000 penalty units or imprisonment for ten years or both, and on summary conviction a fine of 5,000 penalty units or imprisonment for six months or both, with forfeiture of all articles in respect of which the offence was committed. Fine and imprisonment may be cumulative ('or to both'). Section 39(4) gives attempting, soliciting and inciting the same punishment, and section 39(3) requires the consent of the Director of Public Prosecutions for proceedings under section 39(1)(a). The Act's drug provisions state no death penalty. The Act does not state the value of a penalty unit and none is converted here.
If prescribed / medical: The medical route is in the Dangerous Drugs Act itself. Section 15(1)(c) lets the Minister make rules regulating the issue of prescriptions containing a Part III drug and their dispensing, and section 15(2) requires the rules to authorise a pharmaceutical chemist or chemist and druggist to retail, dispense or compound them in the ordinary course of business. Section 19 limits withdrawal from the store to a registered medical practitioner, licensed pharmacist, registered dentist, qualified veterinary surgeon, an approved plantation hospital attendant, or a person approved for recognised Mission medical work. Section 20 states possession in accordance with the prescription of a registered medical practitioner as a matter the accused may prove. Section 39(3) caps the punishment for an inadvertent breach of the prescription or book keeping rules at a fine not exceeding 100 penalty units without imprisonment. Rules under section 15 other than the 2025 methylamphetamine rules were not located, so the detailed prescription rules are not verified. The Pharmacy and Poisons Act (Cap. 105, reprint as in force 5 February 2024) also speaks to prescriptions for these drugs in its own text. Section 36(4) reads 'A prescription which does not comply with the provisions of this section shall not be accepted by any pharmacist as authority for the sale or supply of any medicine or drug'. Section 37(2) reads that every prescription 'containing any of the drugs to which any Act as to the sale of dangerous drugs, for the time being in force, relates, shall be retained in the custody of the pharmacist dispensing the same for a period of two years and filed in the pharmacy'. Section 38(c) provides that a pharmacist shall not 'permit any person, other than a registered pharmacist, to dispense or compound any prescription or supply any medicine or drugs containing any of the dangerous drugs to which subsection (2) of section 37 relates'. The Poisons List in Schedule B Part I of the Pharmacy and Poisons Act (as in force 5 February 2024) also lists 'Amphetamines', which restricts retail sale to authorised sellers (section 56(1)(a), (2)); that is a pharmacy sale control and is separate from the drug control above. Whether any specific Adderall product is registered or may be dispensed in Solomon Islands is not stated in the instruments read. The Poisons Rules add a second route that does not replace the drug control. The Fourth Schedule prints 'Amphetamine' (printed page 3020) and 'Dexamphetamine' and 'Dexedrine' (printed page 3025), each without an exception. Rule 11(1) of the Poisons Rules (printed page 3004) reads 'It shall not be lawful to sell any poison included in the Fourth Schedule to these Rules except on and in accordance with the prescription given by a registered medical practitioner, registered dentist or a qualified veterinary surgeon in the form provided by this rule'. The Poisons Rules were read as printed in the 1996 Revised Edition, whose margin notes run to LN 63 of 1988. The 2024 reprint of the Pharmacy and Poisons Act still carries section 61, the power to make rules, and its endnotes show sections 16 to 26, 28 to 32 and 35 repealed by Act No. 5 of 1997 and other sections amended in 2009 and 2023, but the reprint does not print the Rules and nothing read says they were amended or revoked, so the current force of rule 11 and the Fourth Schedule is not established.
Documentation: Importing requires an import authorisation in Form C granted by the Permanent Secretary, Ministry of Health and Medical Services under section 26, and section 28 provides that no dangerous drug shall be imported unless the person to whom it is consigned holds a valid and subsisting import authorisation. Section 29 requires an export authorisation or diversion certificate from a country party to the Convention to accompany the drug, and section 31 sets the transit conditions. The only exemption from the transit rules for quantities is in section 31(5), for quantities that bona fide form part of the medical stores of a ship or aircraft. The sections read state no exemption for a traveller's personal supply, so none is established, and the Convention as defined in section 2 names only the 1912 and 1925 and 1931 instruments.

Dangerous Drugs Act (Cap. 98), reprint as in force 1 October 2009 · attorneygenerals.gov.sb · Proclamations LN 101 of 1987 and LN 6 of 1988 applying Part III, as printed in the 1996 Revised Edition, Cap. 98 subsidiary legislation, printed pages 2821 to 2824 · solomon-islands.tradeportal.org · Pharmacy and Poisons Act (Cap. 105), reprint as in force 5 February 2024, sections 36 to 38 and 52 to 62 and Schedule B Poisons List · attorneygenerals.gov.sb · Dangerous Drugs (Methylamphetamine) Rules 2025, Gazette No. 158 of 5 November 2025 · solomons.gov.sb · Chemical identity source, cited as an identity record and not as law: DailyMed label for Adderall tablets, US National Library of Medicine · dailymed.nlm.nih.gov · Poisons Rules under the Pharmacy and Poisons Act (Cap. 105), 1996 Revised Edition, printed pages 3000 to 3043, rule 11 and the Fourth Schedule · solomon-islands.tradeportal.org · Updated October 7, 2026

Adderall in Solomon Islands, full detail →

Alcohol

Legal status: Legal, with limits. Alcohol is lawful to sell and drink in Solomon Islands within the Liquor Act (Cap. 144), reprint as in force at 5 February 2024. Section 2 defines 'liquor' as 'any wine, spirits, beer, or any liquid containing alcohol ordinarily used or fit for use as a beverage, or any other liquid which the Minister may by notice declare to be liquor', excluding alcohol whose importation is restricted under section 34 of the Customs and Excise Act, which was not read. Selling liquor needs one of the licences listed in section 3, and section 57(1) makes selling without a licence an offence. Limits found: under a retail licence, sales only on weekdays other than Good Friday and Christmas Day between eight in the forenoon and six in the evening (section 5, which governs the retail licence alone); under a publican's licence section 10 sets different hours, namely weekdays other than Good Friday and Christmas Day from ten in the forenoon to half past ten in the evening, and Sundays, Good Friday and Christmas Day from twelve noon to half past two in the afternoon and from seven to ten in the evening, with a further hours permit possible under section 10(2); a minimum age of twenty one years for the sale and supply offences (section 72); a ban on consuming liquor in streets and public places in a town area (section 65) and in motor vehicles on a road (section 66); and a ban on brewing or distilling without the Minister's written approval (section 50). The Dangerous Drugs Act and the Pharmacy and Poisons Act do not treat alcohol as a drug or poison in the sections read.
Consequences if caught: Sale without a licence: section 57(1) states a fine of 2,000 penalty units for a first offence, and for a second or later offence a fine of 10,000 penalty units or imprisonment for one year or both, with forfeiture of the liquor and, on a repeat, twelve months disqualification from holding a licence. Sale or supply to a person under twenty one: section 72(1) and (2) state a fine of 8,000 penalty units or imprisonment for nine months or both. A person under twenty one who consumes, buys or tries to buy liquor in licensed premises: section 72(3) states a fine of 10,000 penalty units or imprisonment for one year. Sending a person under twenty one to obtain liquor: section 72(4), a fine of 2,000 penalty units. Drinking in a street or public place in a town area: section 65, a fine of 2,000 penalty units. Drinking in a motor vehicle on a road: section 66(3), a fine of 10,000 penalty units or imprisonment for twelve months or both. Brewing, distilling, making liquor or holding a still without approval: section 50(2), a fine of 30,000 penalty units or imprisonment for three years or both. Sale outside the hours: section 5(2), a fine of 3,000 penalty units per sale. A licensee supplying a person who is intoxicated: section 68, 250 penalty units for a first offence and 3,000 for a later one. Publican's licence: section 10(3) forbids the holder to sell or deliver liquor in unbroken containers, or liquor not intended to be consumed on the premises, after nine o'clock in the evening on any day; section 10(6) makes a person (other than a bona fide lodger, the guest of a lodger or a person employed at the premises) who drinks liquor in licensed premises, or is found leaving them with liquor, outside the hours and days in section 10(1) guilty of an offence with a fine of 1,500 penalty units. Licensed premises: section 69(2) makes a person referred to in section 69(1), such as one who is drunk, violent, quarrelsome or disorderly, who refuses or fails to leave when requested by the licensee, his agent or servant or a police officer liable to a fine of 5,000 penalty units or, in default of payment, imprisonment for six months. Private possession and drinking by an adult at home: no offence was found in the Act as read, except under a court order. Section 71 lets a court, on the application of a police officer and on proof that a person is 'of confirmed intemperate habits', prohibit that person from having liquor in possession or drinking it for a period not exceeding twelve months, and section 71(2) makes a person who breaches such an order liable to a fine of 1,000 penalty units or imprisonment for one month or both. Import of liquor: the Liquor Act as read states no offence for importing liquor beyond the still and equipment offence in section 50(2)(a). The Liquor Act states no death penalty. The Act does not state the value of a penalty unit and none is converted here.
If prescribed / medical: Alcohol is not a prescription drug under the Act. The only medical reference is the proviso to section 57(1), which exempts a registered pharmacist supplying liquor in quantities not exceeding six ounces on the prescription of a person registered as a medical practitioner under the Medical and Dental Practitioners Act. Alcohol in medicines is addressed by section 50 of the Pharmacy and Poisons Act only as a labelling duty for imported medicines (percentage of proof spirit).
Documentation: The Liquor Act as read does not set a traveller's allowance or an import permit rule for liquor. Its definition excludes alcohol whose importation is restricted under section 34 of the Customs and Excise Act, and that Act was not read, so the rules for carrying liquor into Solomon Islands are not verified. Section 50(2)(a) separately makes it an offence, without the Minister's written approval, to import a still or equipment for brewing or distilling liquor. Methylated spirits are listed in Part II of the Poisons List in Schedule B of the Pharmacy and Poisons Act, which is a separate regime.

Liquor Act (Cap. 144), reprint as in force 5 February 2024, sections 2, 3, 5, 10, 50, 57, 65, 66, 68, 69, 71 and 72 · attorneygenerals.gov.sb · Pharmacy and Poisons Act (Cap. 105), reprint as in force 5 February 2024, Schedule B Part II · attorneygenerals.gov.sb · Updated October 7, 2026

Alcohol in Solomon Islands, full detail →

Amphetamine

Legal status: Controlled. Amphetamine is named in both proclamations that apply Part III of the Dangerous Drugs Act (Cap. 98, reprint as in force at 1 October 2009) under section 13(2). In the schedule to the proclamation of 21 September 1987 (LN 101 of 1987), printed page 2821, paragraph 1 lists 'Amphetamine' and also 'Dexamphetamine' and 'Dexedrine'. The second list in paragraph 6 on printed page 2823 prints the word 'Amohetamine' where the name should be, which is an apparent printing error on that page, so the verdict does not rest on it. It rests on paragraph 1 and on paragraph (e) of LN 6 of 1988 on printed page 2824 ('The following substances and products, namely:... Amphetamine...'). Paragraph 4 extends Part III to 'any salt of a substance specified in any of paragraphs 1 to 3', paragraph 2 to stereoisomeric forms, and paragraph 5 to 'Any preparations or other product containing a substance of product specified in any of paragraphs 1 to 4, not being a preparation specified in Schedule 1'; no Schedule 1 appears in the pages read, so which preparations stand outside the control is not established. LN 6 of 1988 paragraphs (d) and (h) (printed page 2824) refer instead to 'the Schedule to the Proclamation referred to in paragraph (a)', so 'Schedule 1' in LN 101 paragraphs 5 and 9 may mean the paragraph 1 list of that Schedule; no instrument read states that reading. The instruments read do not state what difference follows from a substance appearing in the second list; they state no separate penalty for it. The margin note on printed page 2824 reads LN 61/1988 while the schedule heading on page 2821 and the 2025 Rules cite LN 6 of 1988. Schedule B Part I of the Pharmacy and Poisons Act (as in force 5 February 2024) also lists 'Amphetamines (beta-aminopropylbenzene and beta-amino-isopropylbenzene)' as a poison, which is a sale restriction and separate from drug control. The Dangerous Drugs (Methylamphetamine) Rules 2025 deal with methylamphetamine only and are not the rule for amphetamine.
Consequences if caught: Amphetamine as a Part III drug: Part III drugs carry these provisions. Personal possession: section 20 makes it an offence against the Act where a Part III drug is found in a person's possession or kept in any place other than the appointed store, unless he can prove that it was obtained under the authority of the Act, or in accordance with the prescription of a registered medical practitioner, or from a person having authority to sell it, or was deposited there without his knowledge or consent. The burden of proof is on the accused, and the section sets no quantity threshold. Possession for supply, sale and trafficking: the Act's text states no separate offence for these for Part III drugs. Sale and distribution are left to rules the Minister may make under section 15(1)(b), and the only rules located are the 2025 methylamphetamine rules, so for this substance a sale offence is not verified beyond the general offence in section 39(1)(a) of contravening the Act or a rule under it. Import and export: sections 14, 23, 25, 28 and 30 prohibit them except in accordance with sections 22 to 30, and section 3 limits entry and exit to a port approved by notice; a person exporting in contravention is also liable under section 35(2) to forfeit treble the value of the goods or 2,000 penalty units at the option of the Comptroller of Customs and Excise. Manufacture: section 15(1)(a) lets rules prohibit manufacture except on licensed premises, and no manufacture offence is stated in the Act's text itself. Cultivation: not applicable to a synthetic or manufactured substance. Use or consumption: the instruments read state no separate offence of use for Part III drugs, so possession under section 20 is the exposure. Administrative offences: section 39(1)(b) and (c) cover breach of licence conditions and false statements to obtain a licence. Penalty: no penalty is otherwise prescribed, so section 39(2) applies to each offence, namely on conviction by the court sitting with assessors a fine of 100,000 penalty units or imprisonment for ten years or both, and on summary conviction a fine of 5,000 penalty units or imprisonment for six months or both, with forfeiture of all articles in respect of which the offence was committed. Fine and imprisonment may be cumulative ('or to both'). Section 39(4) gives attempting, soliciting and inciting the same punishment, and section 39(3) requires the consent of the Director of Public Prosecutions for proceedings under section 39(1)(a). The Act's drug provisions state no death penalty. The Act does not state the value of a penalty unit and none is converted here.
If prescribed / medical: The medical route is in the Dangerous Drugs Act itself. Section 15(1)(c) lets the Minister make rules regulating the issue of prescriptions containing a Part III drug and their dispensing, and section 15(2) requires the rules to authorise a pharmaceutical chemist or chemist and druggist to retail, dispense or compound them in the ordinary course of business. Section 19 limits withdrawal from the store to a registered medical practitioner, licensed pharmacist, registered dentist, qualified veterinary surgeon, an approved plantation hospital attendant, or a person approved for recognised Mission medical work. Section 20 states possession in accordance with the prescription of a registered medical practitioner as a matter the accused may prove. Section 39(3) caps the punishment for an inadvertent breach of the prescription or book keeping rules at a fine not exceeding 100 penalty units without imprisonment. Rules under section 15 other than the 2025 methylamphetamine rules were not located, so the detailed prescription rules are not verified. The Pharmacy and Poisons Act (Cap. 105, reprint as in force 5 February 2024) also speaks to prescriptions for these drugs in its own text. Section 36(4) reads 'A prescription which does not comply with the provisions of this section shall not be accepted by any pharmacist as authority for the sale or supply of any medicine or drug'. Section 37(2) reads that every prescription 'containing any of the drugs to which any Act as to the sale of dangerous drugs, for the time being in force, relates, shall be retained in the custody of the pharmacist dispensing the same for a period of two years and filed in the pharmacy'. Section 38(c) provides that a pharmacist shall not 'permit any person, other than a registered pharmacist, to dispense or compound any prescription or supply any medicine or drugs containing any of the dangerous drugs to which subsection (2) of section 37 relates'. The Poisons List in Schedule B Part I of the Pharmacy and Poisons Act (as in force 5 February 2024) also lists 'Amphetamines', which restricts retail sale to authorised sellers (section 56(1)(a), (2)); that is a pharmacy sale control and is separate from the drug control above. Section 57 of that Act exempts a medicine supplied by a qualified medical practitioner or dispensed by a registered pharmacist, subject to section 57(2) to (5). The Poisons Rules add a prescription only sale rule for the substance. The Fourth Schedule prints 'Amphetamine' with no exception (printed page 3020), and 'Dexamphetamine' and 'Dexedrine' (printed page 3025). Rule 11(1) of the Poisons Rules (printed page 3004) reads 'It shall not be lawful to sell any poison included in the Fourth Schedule to these Rules except on and in accordance with the prescription given by a registered medical practitioner, registered dentist or a qualified veterinary surgeon in the form provided by this rule'. Rule 11(2) applies it to a sale even where the sale is exempted by section 57 of the Act, but not to a sale exempted by section 58. This is a sale rule and is separate from drug control. Whether these Rules are still in force is not established: the copy read is the 1996 Revised Edition (margin notes to LN 63 of 1988), the 2024 reprint of the Act keeps the rule making power in section 61 but does not print the Rules, its endnotes record repeals of sections 16 to 26, 28 to 32 and 35 by Act No. 5 of 1997 and amendments in 2009 and 2023, and nothing read states that the Rules were amended or revoked.
Documentation: Importing requires an import authorisation in Form C granted by the Permanent Secretary, Ministry of Health and Medical Services under section 26, and section 28 provides that no dangerous drug shall be imported unless the person to whom it is consigned holds a valid and subsisting import authorisation. Section 29 requires an export authorisation or diversion certificate from a country party to the Convention to accompany the drug, and section 31 sets the transit conditions. The only exemption from the transit rules for quantities is in section 31(5), for quantities that bona fide form part of the medical stores of a ship or aircraft. The sections read state no exemption for a traveller's personal supply, so none is established, and the Convention as defined in section 2 names only the 1912 and 1925 and 1931 instruments.

Dangerous Drugs Act (Cap. 98), reprint as in force 1 October 2009 · attorneygenerals.gov.sb · Proclamations LN 101 of 1987 and LN 6 of 1988 applying Part III, as printed in the 1996 Revised Edition, Cap. 98 subsidiary legislation, printed pages 2821 to 2824 · solomon-islands.tradeportal.org · Pharmacy and Poisons Act (Cap. 105), reprint as in force 5 February 2024, sections 36 to 38 and 52 to 62 and Schedule B Poisons List · attorneygenerals.gov.sb · Dangerous Drugs (Methylamphetamine) Rules 2025, Gazette No. 158 of 5 November 2025 · solomons.gov.sb · Poisons Rules under the Pharmacy and Poisons Act (Cap. 105), 1996 Revised Edition, printed pages 3000 to 3043, rule 11 and the Fourth Schedule · solomon-islands.tradeportal.org · Updated October 7, 2026

Amphetamine in Solomon Islands, full detail →

Amyl Nitrite

Legal status: Restricted as a poison, with sale by or under the supervision of a registered pharmacist. Amyl nitrite is listed in Schedule B Part I (the Poisons List) of the Pharmacy and Poisons Act (Cap. 105), reprint as in force at 5 February 2024, as 'Amyl nitrite.' Section 2 defines 'poison' as including 'the several substances mentioned in the poisons list in Schedule B', and section 52(2) makes it unlawful to sell or deal in a listed article except in the manner the Act prescribes. This is a pharmacy sale control and not a drug control entry. Amyl nitrite is not named in the Dangerous Drugs Act (Cap. 98, reprint as in force at 1 October 2009) or in the two proclamations (LN 101 of 1987 and LN 6 of 1988) as read from the page images, and no generic clause there reaches it. Because the Dangerous Drugs Act is delegated, with Part III extendable by proclamation under section 13(2) and later proclamations not all read, this is a finding about the Poisons List regime only and not a finding that the Dangerous Drugs Act does not apply. A reported Dangerous Drugs (Amendment) Bill 2025 was not read. The margin of printed page 2824, where the second proclamation is printed, reads LN 61/1988, while the heading on page 2821 and the 2025 Rules cite LN 6 of 1988.
Consequences if caught: Sale and dealing: section 52(2) states 'It shall not be lawful for any person to sell or deal in any of the several articles included in Schedule B hereto hereinafter referred to as the Poisons List, except in the manner prescribed in this Act', and section 56(1)(a) allows a Part I poison to be sold only by an authorised seller of poisons, on premises registered under section 55, by or under the supervision of a registered pharmacist. Section 56(2)(a) requires the buyer to be certified or known to be a person to whom the poison may properly be sold, with the proviso that no poison is sold or delivered to a person under twenty one years, and section 56(2)(b) requires a Poisons Book entry signed by the purchaser. Section 54(c) bars any Poisons Licence for Part I poisons. Import: section 52(1) makes importing any poison unlawful except under a licence issued by the Board, with a proviso for qualified medical practitioners, registered pharmacists, qualified veterinary surgeons and qualified dentists importing for bona fide treatment. Penalty: section 52(5) states 'Any person acting in contravention of this section shall be liable to a penalty of 5,000 penalty units', and for a continuing offence a further 300 penalty units for each day after conviction. A breach of section 56 with no specific penalty falls under section 62(1), 'a penalty of not more than 3,000 penalty units', and 600 penalty units a day for a continuing offence. These are fines stated without imprisonment. Possession and use by a member of the public: the Pharmacy and Poisons Act as read states no offence of possessing or using a poison. Manufacture, cultivation and export: no offence is stated beyond the general rule making power in section 61. The Pharmacy and Poisons Act states no death penalty. The Act does not state the value of a penalty unit and none is converted here. These are the Pharmacy and Poisons Act penalties only. Whether a proclamation not read applies the Dangerous Drugs Act to this substance is not established.
If prescribed / medical: The medicines route is in the Pharmacy and Poisons Act. Section 57(1) states that the poisons sale restrictions do not apply 'to a medicine which is supplied by a qualified medical practitioner for the purposes of medical treatment' or 'to a medicine which is dispensed by a registered pharmacist at his place of business', or to a poison forming part of the ingredients of such a medicine, subject to the labelling and prescription book requirements in section 57(2) to (5). Section 61(1)(b)(ii) lets the Board make rules prohibiting retail sale of Part I poisons except on a prescription. The Poisons Rules in the 1996 Revised Edition were read for this substance: rule 11(1) requires a prescription for a poison in the Fourth Schedule, but the Fourth Schedule (printed pages 3019 to 3042) does not print amyl nitrite, and the names either side of it on printed page 3020, 'Amylobarbitone' and 'Amylocaine Hydrochloride', are separate entries. No prescription only rule for amyl nitrite was found. The current force of the Poisons Rules is not established: only the 1996 Revised Edition was read, the 2024 reprint of the Act has section 61 (rules) and endnotes showing repeals by Act No. 5 of 1997 and amendments in 2009 and 2023, does not print the Rules, and nothing read says they were amended or revoked.
Documentation: Section 52(1) of the Pharmacy and Poisons Act makes importing any poison unlawful except under a licence issued by the Board, with a proviso for qualified medical practitioners, registered pharmacists, qualified veterinary surgeons and qualified dentists importing for bona fide medical, veterinary or dental treatment, and section 52(5) states the penalty of 5,000 penalty units. No traveller's personal supply exemption is stated in the sections read, so none is established. The import authorisation scheme of the Dangerous Drugs Act applies only to drugs to which Part III applies, which is not shown for this substance.

Pharmacy and Poisons Act (Cap. 105), reprint as in force 5 February 2024, sections 52 to 62 and Schedule B Poisons List · attorneygenerals.gov.sb · Dangerous Drugs Act (Cap. 98), reprint as in force 1 October 2009 · attorneygenerals.gov.sb · Proclamations LN 101 of 1987 and LN 6 of 1988 applying Part III, as printed in the 1996 Revised Edition, Cap. 98 subsidiary legislation, printed pages 2821 to 2824 · solomon-islands.tradeportal.org · Poisons Rules under the Pharmacy and Poisons Act (Cap. 105), 1996 Revised Edition, printed pages 3000 to 3043, rule 11 and the Fourth Schedule · solomon-islands.tradeportal.org · Updated October 7, 2026

Amyl Nitrite in Solomon Islands, full detail →

Barbiturates

Legal status: Restricted as a poison, with sale by or under the supervision of a registered pharmacist. Barbiturates are a class slug and are answered by the range of one Poisons List entry, not by any single member. Schedule B Part I of the Pharmacy and Poisons Act (Cap. 105), reprint as in force at 5 February 2024, lists 'Barbituric acid; its salts; derivatives of barbituric acid; their salts; compounds of barbituric acid, its salts, its derivatives, their salts with any other substance.' The Act names no individual barbiturate, and whether a particular drug is a derivative of barbituric acid is a chemical question the Act does not state. That barbiturates are by definition the derivatives of barbituric acid is chemical background from outside the instruments read, and no verdict rests on it beyond the printed names listed below. The Poisons Rules in the 1996 Revised Edition do name members one by one. Their First Schedule repeats the class entry ('Barbituric acid, its salts, derivatives of barbituric acid, their salts, compounds of barbituric acids, its salts, its derivatives, their salts, with any other substance', printed page 3014), and their Fourth Schedule prints these entries whose printed names contain 'barbitone', 'barbiturate' or 'barbituric': Allobarbitone (printed page 3019); Amylobarbitone (3020); Aprobarbitone (3020); Barbitone (3021); Butobarbitone (3023); 'Calcium 5-Allyl-5-N-Butylbarbiturate' (3023); Cyclobarbitone (3024); Heptabarbitone (3028); Hexobarbitone (3028); Metharbitone (3033); Methylphenobarbitone (3033); Nealbarbitone (3034); 'Pentbarbitone' (3036, with 'Pentobarbitone Sodium' beneath it); Phenobarbitone (3036); 'Phenylmethylbarbituric Acid' (3036); Quinalbarbitone (3038); 'Quiuidine Pheuylethylbarbiturate' (3038, quoted as printed); Secbutobarbitone (3039); 'Secbutibarbitone Sodium' (3039); Thialbarbitone (3041); and Vinbarbitone (3042). Most of these also print a sodium or calcium salt as a further entry. 'Butalbital' (3022) and 'Thiopentone Sodium' (3041) are printed without any such syllable, and no instrument read states their chemical class, so they are not counted. The verdict states the Poisons List position of the 2024 text; the prescription rule in the Fourth Schedule is described in the prescription field, where its current force is stated as not established. Section 52(2) makes it unlawful to sell or deal in a listed article except in the manner the Act prescribes. This is a pharmacy sale control and not a drug control entry. No barbiturate is named in the Dangerous Drugs Act (Cap. 98, reprint as in force at 1 October 2009) or in the proclamations LN 101 of 1987 and LN 6 of 1988 as read from the page images; methaqualone is named there, and no instrument read states its chemical class. Because the Dangerous Drugs Act is delegated and later proclamations were not all read, this is a finding about the Poisons List regime only. A reported Dangerous Drugs (Amendment) Bill 2025 was not read. The margin of printed page 2824, where the second proclamation is printed, reads LN 61/1988, while the heading on page 2821 and the 2025 Rules cite LN 6 of 1988.
Consequences if caught: Sale and dealing: section 52(2) states 'It shall not be lawful for any person to sell or deal in any of the several articles included in Schedule B hereto hereinafter referred to as the Poisons List, except in the manner prescribed in this Act', and section 56(1)(a) allows a Part I poison to be sold only by an authorised seller of poisons, on premises registered under section 55, by or under the supervision of a registered pharmacist. Section 56(2)(a) requires the buyer to be certified or known to be a person to whom the poison may properly be sold, with the proviso that no poison is sold or delivered to a person under twenty one years, and section 56(2)(b) requires a Poisons Book entry signed by the purchaser. Section 54(c) bars any Poisons Licence for Part I poisons. Import: section 52(1) makes importing any poison unlawful except under a licence issued by the Board, with a proviso for qualified medical practitioners, registered pharmacists, qualified veterinary surgeons and qualified dentists importing for bona fide treatment. Penalty: section 52(5) states 'Any person acting in contravention of this section shall be liable to a penalty of 5,000 penalty units', and for a continuing offence a further 300 penalty units for each day after conviction. A breach of section 56 with no specific penalty falls under section 62(1), 'a penalty of not more than 3,000 penalty units', and 600 penalty units a day for a continuing offence. These are fines stated without imprisonment. Possession and use by a member of the public: the Pharmacy and Poisons Act as read states no offence of possessing or using a poison. Manufacture, cultivation and export: no offence is stated beyond the general rule making power in section 61. The Pharmacy and Poisons Act states no death penalty. The Act does not state the value of a penalty unit and none is converted here. These are the Pharmacy and Poisons Act penalties only. Whether a proclamation not read applies the Dangerous Drugs Act to this substance is not established.
If prescribed / medical: The medicines route is in the Pharmacy and Poisons Act. Section 57(1) states that the poisons sale restrictions do not apply 'to a medicine which is supplied by a qualified medical practitioner for the purposes of medical treatment' or 'to a medicine which is dispensed by a registered pharmacist at his place of business', or to a poison forming part of the ingredients of such a medicine, subject to the labelling and prescription book requirements in section 57(2) to (5). Section 61(1)(b)(ii) lets the Board make rules prohibiting retail sale of Part I poisons except on a prescription, and rules of that kind are in the 1996 Revised Edition of the Poisons Rules. Rule 11(1) of the Poisons Rules (printed page 3004) reads 'It shall not be lawful to sell any poison included in the Fourth Schedule to these Rules except on and in accordance with the prescription given by a registered medical practitioner, registered dentist or a qualified veterinary surgeon in the form provided by this rule'. The Fourth Schedule prints the entries set out in the status field, from Allobarbitone (printed page 3019) to Vinbarbitone (printed page 3042); 'Butalbital' (3022) and 'Thiopentone Sodium' (3041) print no barbiturate syllable and are not counted. Rule 11(2) applies the rule to a sale even where the sale is exempted by section 57 of the Act, but not to a sale exempted by section 58. The Poisons Rules were read as printed in the 1996 Revised Edition, whose margin notes run to LN 63 of 1988. The 2024 reprint of the Pharmacy and Poisons Act still carries section 61, the power to make rules, and its endnotes show sections 16 to 26, 28 to 32 and 35 repealed by Act No. 5 of 1997 and other sections amended in 2009 and 2023, but the reprint does not print the Rules and nothing read says they were amended or revoked, so the current force of rule 11 and the Fourth Schedule is not established.
Documentation: Section 52(1) of the Pharmacy and Poisons Act makes importing any poison unlawful except under a licence issued by the Board, with a proviso for qualified medical practitioners, registered pharmacists, qualified veterinary surgeons and qualified dentists importing for bona fide medical, veterinary or dental treatment, and section 52(5) states the penalty of 5,000 penalty units. No traveller's personal supply exemption is stated in the sections read, so none is established. The import authorisation scheme of the Dangerous Drugs Act applies only to drugs to which Part III applies, which is not shown for this substance.

Pharmacy and Poisons Act (Cap. 105), reprint as in force 5 February 2024, sections 52 to 62 and Schedule B Poisons List · attorneygenerals.gov.sb · Dangerous Drugs Act (Cap. 98), reprint as in force 1 October 2009 · attorneygenerals.gov.sb · Proclamations LN 101 of 1987 and LN 6 of 1988 applying Part III, as printed in the 1996 Revised Edition, Cap. 98 subsidiary legislation, printed pages 2821 to 2824 · solomon-islands.tradeportal.org · Poisons Rules under the Pharmacy and Poisons Act (Cap. 105), 1996 Revised Edition, printed pages 3000 to 3043, rule 11 and the First and Fourth Schedules · solomon-islands.tradeportal.org · Updated October 7, 2026

Barbiturates in Solomon Islands, full detail →

Buprenorphine

Legal status: Controlled. Buprenorphine is a named Part III drug. The schedule to the proclamation of 21 September 1987 (LN 101 of 1987), printed page 2821 of the 1996 Revised Edition, applies Part III of the Dangerous Drugs Act (Cap. 98, reprint as in force at 1 October 2009) under section 13(2) to a list that includes 'Buprenorphine' in its second column. Paragraph 4 of the same schedule extends Part III to 'any salt of a substance specified in any of paragraphs 1 to 3', so a salt is within the control, and paragraph 5 extends it to 'Any preparations or other product containing a substance of product specified in any of paragraphs 1 to 4, not being a preparation specified in Schedule 1'. No Schedule 1 appears in the pages read, so whether a given tablet or injection is inside or outside the control is not established. LN 6 of 1988 paragraphs (d) and (h) (printed page 2824) refer instead to 'the Schedule to the Proclamation referred to in paragraph (a)', so 'Schedule 1' in LN 101 paragraphs 5 and 9 may mean the paragraph 1 list of that Schedule; no instrument read states that reading. Buprenorphine is not in the Poisons List in Schedule B of the Pharmacy and Poisons Act as in force at 5 February 2024 (searched as 'Buprenorphine'), but the Fourth Schedule to the Poisons Rules (1996 Revised Edition) prints 'Buprenorphine' and 'Buprenorphine Hydrochloride' on printed page 3022. That is a prescription only sale rule under rule 11(1), separate from drug control and set out in the prescription field. Section 21(1) of the Act bars trade in products obtained from the phenanthrene alkaloids of opium that were not in medical or scientific use on 13 July 1931, unless the Minister proclaims otherwise; the instruments read do not say whether buprenorphine is such a product, so no view is given.
Consequences if caught: Buprenorphine as a Part III drug: Part III drugs carry these provisions. Personal possession: section 20 makes it an offence against the Act where a Part III drug is found in a person's possession or kept in any place other than the appointed store, unless he can prove that it was obtained under the authority of the Act, or in accordance with the prescription of a registered medical practitioner, or from a person having authority to sell it, or was deposited there without his knowledge or consent. The burden of proof is on the accused, and the section sets no quantity threshold. Possession for supply, sale and trafficking: the Act's text states no separate offence for these for Part III drugs. Sale and distribution are left to rules the Minister may make under section 15(1)(b), and the only rules located are the 2025 methylamphetamine rules, so for this substance a sale offence is not verified beyond the general offence in section 39(1)(a) of contravening the Act or a rule under it. Import and export: sections 14, 23, 25, 28 and 30 prohibit them except in accordance with sections 22 to 30, and section 3 limits entry and exit to a port approved by notice; a person exporting in contravention is also liable under section 35(2) to forfeit treble the value of the goods or 2,000 penalty units at the option of the Comptroller of Customs and Excise. Manufacture: section 15(1)(a) lets rules prohibit manufacture except on licensed premises, and no manufacture offence is stated in the Act's text itself. Cultivation: not applicable to a synthetic or manufactured substance. Use or consumption: the instruments read state no separate offence of use for Part III drugs, so possession under section 20 is the exposure. Administrative offences: section 39(1)(b) and (c) cover breach of licence conditions and false statements to obtain a licence. Penalty: no penalty is otherwise prescribed, so section 39(2) applies to each offence, namely on conviction by the court sitting with assessors a fine of 100,000 penalty units or imprisonment for ten years or both, and on summary conviction a fine of 5,000 penalty units or imprisonment for six months or both, with forfeiture of all articles in respect of which the offence was committed. Fine and imprisonment may be cumulative ('or to both'). Section 39(4) gives attempting, soliciting and inciting the same punishment, and section 39(3) requires the consent of the Director of Public Prosecutions for proceedings under section 39(1)(a). The Act's drug provisions state no death penalty. The Act does not state the value of a penalty unit and none is converted here.
If prescribed / medical: The medical route is in the Dangerous Drugs Act itself. Section 15(1)(c) lets the Minister make rules regulating the issue of prescriptions containing a Part III drug and their dispensing, and section 15(2) requires the rules to authorise a pharmaceutical chemist or chemist and druggist to retail, dispense or compound them in the ordinary course of business. Section 19 limits withdrawal from the store to a registered medical practitioner, licensed pharmacist, registered dentist, qualified veterinary surgeon, an approved plantation hospital attendant, or a person approved for recognised Mission medical work. Section 20 states possession in accordance with the prescription of a registered medical practitioner as a matter the accused may prove. Section 39(3) caps the punishment for an inadvertent breach of the prescription or book keeping rules at a fine not exceeding 100 penalty units without imprisonment. Rules under section 15 other than the 2025 methylamphetamine rules were not located, so the detailed prescription rules are not verified. The Pharmacy and Poisons Act (Cap. 105, reprint as in force 5 February 2024) also speaks to prescriptions for these drugs in its own text. Section 36(4) reads 'A prescription which does not comply with the provisions of this section shall not be accepted by any pharmacist as authority for the sale or supply of any medicine or drug'. Section 37(2) reads that every prescription 'containing any of the drugs to which any Act as to the sale of dangerous drugs, for the time being in force, relates, shall be retained in the custody of the pharmacist dispensing the same for a period of two years and filed in the pharmacy'. Section 38(c) provides that a pharmacist shall not 'permit any person, other than a registered pharmacist, to dispense or compound any prescription or supply any medicine or drugs containing any of the dangerous drugs to which subsection (2) of section 37 relates'. It is not a Poisons List article, but the Poisons Rules reach it by name. The Fourth Schedule prints 'Buprenorphine' and 'Buprenorphine Hydrochloride' with no exception (printed page 3022). Rule 11(1) of the Poisons Rules (printed page 3004) reads 'It shall not be lawful to sell any poison included in the Fourth Schedule to these Rules except on and in accordance with the prescription given by a registered medical practitioner, registered dentist or a qualified veterinary surgeon in the form provided by this rule'. Rule 11(2) applies it to a sale even where the sale is exempted by section 57 of the Act, but not to a sale exempted by section 58. The Poisons Rules were read as printed in the 1996 Revised Edition, whose margin notes run to LN 63 of 1988. The 2024 reprint of the Pharmacy and Poisons Act still carries section 61, the power to make rules, and its endnotes show sections 16 to 26, 28 to 32 and 35 repealed by Act No. 5 of 1997 and other sections amended in 2009 and 2023, but the reprint does not print the Rules and nothing read says they were amended or revoked, so the current force of rule 11 and the Fourth Schedule is not established.
Documentation: Importing requires an import authorisation in Form C granted by the Permanent Secretary, Ministry of Health and Medical Services under section 26, and section 28 provides that no dangerous drug shall be imported unless the person to whom it is consigned holds a valid and subsisting import authorisation. Section 29 requires an export authorisation or diversion certificate from a country party to the Convention to accompany the drug, and section 31 sets the transit conditions. The only exemption from the transit rules for quantities is in section 31(5), for quantities that bona fide form part of the medical stores of a ship or aircraft. The sections read state no exemption for a traveller's personal supply, so none is established, and the Convention as defined in section 2 names only the 1912 and 1925 and 1931 instruments.

Dangerous Drugs Act (Cap. 98), reprint as in force 1 October 2009 · attorneygenerals.gov.sb · Proclamations LN 101 of 1987 and LN 6 of 1988 applying Part III, as printed in the 1996 Revised Edition, Cap. 98 subsidiary legislation, printed pages 2821 to 2824 · solomon-islands.tradeportal.org · Pharmacy and Poisons Act (Cap. 105), reprint as in force 5 February 2024, sections 36 to 38 and 52 to 62 and Schedule B Poisons List · attorneygenerals.gov.sb · Dangerous Drugs (Methylamphetamine) Rules 2025, Gazette No. 158 of 5 November 2025 · solomons.gov.sb · Poisons Rules under the Pharmacy and Poisons Act (Cap. 105), 1996 Revised Edition, printed pages 3000 to 3043, rule 11 and the Fourth Schedule · solomon-islands.tradeportal.org · Updated October 7, 2026

Buprenorphine in Solomon Islands, full detail →

Cannabis / THC

Legal status: Controlled. Cannabis is controlled by the text of Part I of the Dangerous Drugs Act (Cap. 98), reprint as in force at 1 October 2009, with no proclamation needed. Section 2 defines 'Indian hemp' as 'either of the plants Cannabis sativa or Cannabis indica or any portion thereof'. Section 4(1) states: 'The provisions of this Part of this Act shall apply to raw opium, coca leaf and Indian hemp and resins obtained from Indian hemp and preparations of which such resins form the base.' So the plant and any part of it, cannabis resin, and preparations based on resin are each within Part I, and they are addressed apart here. Separately, section 13(1)(b) applies Part III to 'any extract or tincture of Indian hemp'. Seeds are covered by section 5, which prohibits import or export of 'any seed of Indian hemp'. Schedule B Part I of the Pharmacy and Poisons Act lists 'Cannabis (the dried flowering or fruiting tops of Cannabis sativa Linn.), the resin of cannabis; extracts of cannabis, tinctures of cannabis; cannabin tannate' as a poison, a sale restriction separate from drug control. No exemption for low THC hemp, CBD products or medical or recreational use was found in the instruments read. A reported Dangerous Drugs (Amendment) Bill 2025 was not read.
Consequences if caught: Cultivation: section 7 states 'No person shall cultivate in Solomon Islands the opium poppy or Indian hemp or coca leaf plant', and section 8(a) makes every person 'growing opium poppy, Indian hemp or coca leaf whether for private use or otherwise' guilty of an offence against the Act. Personal possession, possession for supply, sale and giving: section 8(b) makes guilty of an offence every person 'found in possession of or selling, or who shall have given or sold, to any person any substance to which this Part of this Act applies'. It draws no line between personal possession and possession for supply, sets no quantity threshold, and covers giving as well as selling; no separate trafficking offence is stated. Import and export: section 4(2) states 'No person shall import or export any of the substances to which this Part of this Act applies', section 5 prohibits seeds, and section 6 provides for seizure and forfeiture; section 3 limits entry and exit to an approved port. Manufacture: no separate offence is stated for Part I, and extracts and tinctures fall also under Part III, where manufacture is for rules under section 15(1)(a) that were not located, so that part is not verified. Use or consumption: no separate offence of use is stated for Indian hemp; possession is the exposure. Powers: under section 9(2) a police officer may without warrant apprehend and detain any person carrying or conveying Indian hemp, and section 10 allows seizure and destruction of plants on a plantation. Penalty: Part I states no penalty, so section 39(2), as amended by Act No. 14 of 2009, applies to each offence, namely on conviction by the court sitting with assessors a fine of 100,000 penalty units or imprisonment for ten years or both, and on summary conviction a fine of 5,000 penalty units or imprisonment for six months or both, with forfeiture of all articles in respect of which the offence was committed. Fine and imprisonment may be cumulative ('or to both'). Section 39(4) gives attempting, soliciting and inciting the same punishment. The Act's drug provisions state no death penalty. The Act does not state the value of a penalty unit and none is converted here.
If prescribed / medical: Part I states no medical or prescription route for Indian hemp, its resin or preparations based on resin. For an extract or tincture of Indian hemp, which section 13(1)(b) places in Part III, section 20 states possession in accordance with the prescription of a registered medical practitioner as a matter the accused may prove, and section 15(1)(c) lets rules regulate prescriptions and dispensing; rules under section 15 other than the 2025 methylamphetamine rules were not located, so the detailed prescription rules are not verified. The Pharmacy and Poisons Act (Cap. 105, reprint as in force 5 February 2024) also speaks to prescriptions for these drugs in its own text. Section 36(4) reads 'A prescription which does not comply with the provisions of this section shall not be accepted by any pharmacist as authority for the sale or supply of any medicine or drug'. Section 37(2) reads that every prescription 'containing any of the drugs to which any Act as to the sale of dangerous drugs, for the time being in force, relates, shall be retained in the custody of the pharmacist dispensing the same for a period of two years and filed in the pharmacy'. Section 38(c) provides that a pharmacist shall not 'permit any person, other than a registered pharmacist, to dispense or compound any prescription or supply any medicine or drugs containing any of the dangerous drugs to which subsection (2) of section 37 relates'. The Pharmacy and Poisons Act lists cannabis tops, resin, extracts and tinctures in Schedule B Part I, so retail sale is limited to authorised sellers under section 56 of that Act, and section 57 exempts a medicine supplied by a qualified medical practitioner or dispensed by a registered pharmacist. The Poisons Rules in the 1996 Revised Edition also print 'Cannabis, the resins of cannabis, extracts of cannabis, tinctures of cannabis, cannabin tannate' in the First Schedule (printed page 3014), and rule 9(d) (printed page 3004) provides that the provisions of the Rules that apply solely to First Schedule substances do not apply to 'corn paints in which the only poison is a poison included in the Poisons List under the heading of "Cannabis"'. The current force of those Rules is not established: the copy read is the 1996 Revised Edition (margin notes to LN 63 of 1988), the 2024 reprint of the Act keeps the rule making power in section 61 but does not print the Rules, and nothing read states that the Rules were amended or revoked. No cannabis medicine programme is stated in the instruments read.
Documentation: Import and export of Indian hemp, its resin, preparations based on resin and its seed are prohibited by sections 4(2) and 5 of the Dangerous Drugs Act, and Part I states no authorisation route, so carrying cannabis in any form into or out of Solomon Islands is within the prohibition as read. Seizure and forfeiture follow under section 6. For an extract or tincture, Part III applies and import is only in accordance with sections 22 to 30, which require an import authorisation in Form C from the Permanent Secretary, Ministry of Health and Medical Services (sections 26 and 28). The sections read state no exemption for a traveller's personal supply.

Dangerous Drugs Act (Cap. 98), reprint as in force 1 October 2009 · attorneygenerals.gov.sb · Proclamations LN 101 of 1987 and LN 6 of 1988 applying Part III, as printed in the 1996 Revised Edition, Cap. 98 subsidiary legislation, printed pages 2821 to 2824 · solomon-islands.tradeportal.org · Pharmacy and Poisons Act (Cap. 105), reprint as in force 5 February 2024, sections 36 to 38 and 52 to 62 and Schedule B Poisons List · attorneygenerals.gov.sb · Dangerous Drugs (Methylamphetamine) Rules 2025, Gazette No. 158 of 5 November 2025 · solomons.gov.sb · Poisons Rules under the Pharmacy and Poisons Act (Cap. 105), 1996 Revised Edition, printed pages 3000 to 3043, rule 9 and the First Schedule · solomon-islands.tradeportal.org · Updated October 7, 2026

Cannabis / THC in Solomon Islands, full detail →

Cocaine

Legal status: Controlled. Cocaine is a named Part III drug of the Dangerous Drugs Act (Cap. 98), reprint as in force at 1 October 2009. Section 13(1)(d) applies Part III to 'cocaine (including synthetic cocaine) and ecgonine and their respective salts and the esters of ecgonine and their respective salts', and section 13(1)(e) reaches dilutions, solutions and preparations containing cocaine (for admixtures, 'not less than... one-tenth per centum of cocaine or of ecgonine'). The proclamation of 21 September 1987 (LN 101 of 1987), page 2821 of the 1996 Revised Edition, also lists 'Cocaine' and, on page 2822, 'Ecgonine, and any derivative of ecgonine which is convertible to ecgonine or to cocaine'. The coca plant is separate: Part I applies to 'coca leaf' (section 4(1)), defined in section 2 as the leaf of Erythroxylon coca and Erythroxylon novogranatense and other species of the genus from which cocaine may be extracted, and crude cocaine is defined as any extract of the coca leaf usable for making cocaine. The named entries govern and no generic clause is needed. Schedule B Part I of the Pharmacy and Poisons Act lists 'Cocaine', 'Coca, alkaloids of' and 'Ecgonine; its esters' as poisons, which is a sale restriction and separate from drug control. The Poisons Rules (1996 Revised Edition) also print 'Cocaine' in the First Schedule (printed page 3013) and in the Fourth Schedule (printed page 3024), described in the prescription field.
Consequences if caught: Cocaine as a Part III drug: Part III drugs carry these provisions. Personal possession: section 20 makes it an offence against the Act where a Part III drug is found in a person's possession or kept in any place other than the appointed store, unless he can prove that it was obtained under the authority of the Act, or in accordance with the prescription of a registered medical practitioner, or from a person having authority to sell it, or was deposited there without his knowledge or consent. The burden of proof is on the accused, and the section sets no quantity threshold. Possession for supply, sale and trafficking: the Act's text states no separate offence for these for Part III drugs. Sale and distribution are left to rules the Minister may make under section 15(1)(b), and the only rules located are the 2025 methylamphetamine rules, so for this substance a sale offence is not verified beyond the general offence in section 39(1)(a) of contravening the Act or a rule under it. Import and export: sections 14, 23, 25, 28 and 30 prohibit them except in accordance with sections 22 to 30, and section 3 limits entry and exit to a port approved by notice; a person exporting in contravention is also liable under section 35(2) to forfeit treble the value of the goods or 2,000 penalty units at the option of the Comptroller of Customs and Excise. Manufacture: section 15(1)(a) lets rules prohibit manufacture except on licensed premises, and no manufacture offence is stated in the Act's text itself. Cultivation: the coca plant is a Part I matter, dealt with below. Use or consumption: the instruments read state no separate offence of use for Part III drugs, so possession under section 20 is the exposure. Administrative offences: section 39(1)(b) and (c) cover breach of licence conditions and false statements to obtain a licence. Penalty: no penalty is otherwise prescribed, so section 39(2) applies to each offence, namely on conviction by the court sitting with assessors a fine of 100,000 penalty units or imprisonment for ten years or both, and on summary conviction a fine of 5,000 penalty units or imprisonment for six months or both, with forfeiture of all articles in respect of which the offence was committed. Fine and imprisonment may be cumulative ('or to both'). Section 39(4) gives attempting, soliciting and inciting the same punishment, and section 39(3) requires the consent of the Director of Public Prosecutions for proceedings under section 39(1)(a). The Act's drug provisions state no death penalty. The Act does not state the value of a penalty unit and none is converted here. Coca leaf, which is the plant, is under Part I and is treated separately: section 7 forbids cultivating the coca leaf plant, section 8(a) makes growing it an offence 'whether for private use or otherwise', section 8(b) makes it an offence to be found in possession of or selling or having given or sold any substance to which Part I applies, and section 4(2) and section 5 prohibit import and export of the leaf and of coca seed. Those Part I offences state no penalty of their own, so section 39(2) above applies to them.
If prescribed / medical: The medical route is in the Dangerous Drugs Act itself. Section 15(1)(c) lets the Minister make rules regulating the issue of prescriptions containing a Part III drug and their dispensing, and section 15(2) requires the rules to authorise a pharmaceutical chemist or chemist and druggist to retail, dispense or compound them in the ordinary course of business. Section 19 limits withdrawal from the store to a registered medical practitioner, licensed pharmacist, registered dentist, qualified veterinary surgeon, an approved plantation hospital attendant, or a person approved for recognised Mission medical work. Section 20 states possession in accordance with the prescription of a registered medical practitioner as a matter the accused may prove. Section 39(3) caps the punishment for an inadvertent breach of the prescription or book keeping rules at a fine not exceeding 100 penalty units without imprisonment. Rules under section 15 other than the 2025 methylamphetamine rules were not located, so the detailed prescription rules are not verified. The Pharmacy and Poisons Act (Cap. 105, reprint as in force 5 February 2024) also speaks to prescriptions for these drugs in its own text. Section 36(4) reads 'A prescription which does not comply with the provisions of this section shall not be accepted by any pharmacist as authority for the sale or supply of any medicine or drug'. Section 37(2) reads that every prescription 'containing any of the drugs to which any Act as to the sale of dangerous drugs, for the time being in force, relates, shall be retained in the custody of the pharmacist dispensing the same for a period of two years and filed in the pharmacy'. Section 38(c) provides that a pharmacist shall not 'permit any person, other than a registered pharmacist, to dispense or compound any prescription or supply any medicine or drugs containing any of the dangerous drugs to which subsection (2) of section 37 relates'. The Poisons List in Schedule B Part I of the Pharmacy and Poisons Act (as in force 5 February 2024) also lists 'Cocaine', 'Coca, alkaloids of' and 'Ecgonine; its esters', which restricts retail sale to authorised sellers (section 56(1)(a), (2)); that is a pharmacy sale control and is separate from the drug control above. Section 57 of that Act exempts a medicine supplied by a qualified medical practitioner for treatment or dispensed by a registered pharmacist at his place of business, subject to the labelling and prescription book requirements in section 57(2) to (5). The Poisons Rules add entries of their own. The Fourth Schedule prints 'Cocaine' (printed page 3024) and 'Ecgonine' (printed page 3026), each with no exception, and the First Schedule prints 'Cocaine, except substances containing less than 0.1 per cent of cocaine' (printed page 3013). Rule 11(1) of the Poisons Rules (printed page 3004) reads 'It shall not be lawful to sell any poison included in the Fourth Schedule to these Rules except on and in accordance with the prescription given by a registered medical practitioner, registered dentist or a qualified veterinary surgeon in the form provided by this rule'. Current force is the open point for this Fourth Schedule entry. The Rules were read in the 1996 Revised Edition only. The 2024 reprint of the Act has section 61 (rules) and endnotes showing repeals by Act No. 5 of 1997 and amendments in 2009 and 2023, does not print the Rules, and nothing read says they were amended or revoked.
Documentation: Importing requires an import authorisation in Form C granted by the Permanent Secretary, Ministry of Health and Medical Services under section 26, and section 28 provides that no dangerous drug shall be imported unless the person to whom it is consigned holds a valid and subsisting import authorisation. Section 29 requires an export authorisation or diversion certificate from a country party to the Convention to accompany the drug, and section 31 sets the transit conditions. The only exemption from the transit rules for quantities is in section 31(5), for quantities that bona fide form part of the medical stores of a ship or aircraft. The sections read state no exemption for a traveller's personal supply, so none is established, and the Convention as defined in section 2 names only the 1912 and 1925 and 1931 instruments. Coca leaf and coca seed are Part I substances, and section 4(2) and section 5 prohibit their import and export without stating any authorisation route. A reported Dangerous Drugs (Amendment) Bill 2025 was not read.

Dangerous Drugs Act (Cap. 98), reprint as in force 1 October 2009 · attorneygenerals.gov.sb · Proclamations LN 101 of 1987 and LN 6 of 1988 applying Part III, as printed in the 1996 Revised Edition, Cap. 98 subsidiary legislation, printed pages 2821 to 2824 · solomon-islands.tradeportal.org · Pharmacy and Poisons Act (Cap. 105), reprint as in force 5 February 2024, sections 36 to 38 and 52 to 62 and Schedule B Poisons List · attorneygenerals.gov.sb · Dangerous Drugs (Methylamphetamine) Rules 2025, Gazette No. 158 of 5 November 2025 · solomons.gov.sb · Poisons Rules under the Pharmacy and Poisons Act (Cap. 105), 1996 Revised Edition, printed pages 3000 to 3043, rule 11 and the First and Fourth Schedules · solomon-islands.tradeportal.org · Updated October 7, 2026

Cocaine in Solomon Islands, full detail →

Codeine

Legal status: Controlled. The proclamation text carves out 'a preparation specified in Schedule 1', and what that phrase refers to is not clear. Codeine is named in both lists of the proclamations that apply Part III of the Dangerous Drugs Act (Cap. 98, reprint as in force at 1 October 2009) under section 13(2). Paragraph 1 of the schedule to the proclamation of 21 September 1987 (LN 101 of 1987), printed page 2821 of the 1996 Revised Edition, lists 'Codeine'. Paragraph 6 on printed page 2823 and paragraph (e) of LN 6 of 1988 on printed page 2824 list it again as 'Codeine (Pure substance)'. Two provisions of the Act itself matter for codeine. Section 13(1)(h) takes 'methylmorphine, commonly known as codeine' out of the Act's own list of morphine esters, and section 21(3) lets the Minister apply Part III to codeine 'with such modifications as may be specified in the proclamation'. The proclamation pages read name codeine and print no modification, so on the reading taken here the exception in section 13(1)(h) does not prevent the proclamation from applying Part III to it, and what the second list adds is not stated in the instruments read. Paragraph 4 extends Part III to 'any salt of a substance specified in any of paragraphs 1 to 3', and paragraph 3 (esters and ethers) expressly does not reach substances specified in paragraph 6. Paragraph 5 of the 1987 schedule (and paragraph 9 for the second list) reaches 'any preparations or other product containing a substance' of the earlier paragraphs but excludes 'a preparation specified in Schedule 1'; no Schedule 1 appears in the pages read and no order under section 13(3) was read, so which preparations are outside the control is not established. LN 6 of 1988 paragraphs (d) and (h) (printed page 2824) refer instead to 'the Schedule to the Proclamation referred to in paragraph (a)', so 'Schedule 1' in LN 101 paragraphs 5 and 9 may mean the paragraph 1 list of that Schedule; no instrument read states that reading. The margin note on printed page 2824 reads LN 61/1988 while the heading on page 2821 and the 2025 Rules cite LN 6 of 1988, and paragraph (g) is absent between (f) and (h) on page 2824. Ethylmorphine and dihydrocodeine are listed beside codeine in both lists as separate entries and are not the answer for codeine. Codeine is also in Schedule B Part I of the Pharmacy and Poisons Act (as in force 5 February 2024), among the alkaloids, which is a sale restriction and separate from drug control.
Consequences if caught: Codeine as a Part III drug through the proclamations: Personal possession: section 20 makes it an offence against the Act when a Part III drug is found in a person's possession or kept in any place other than the appointed store, unless he can prove that it was obtained under the authority of the Act, or in accordance with the prescription of a registered medical practitioner, or from a person having authority to sell it, or was deposited there without his knowledge or consent. The burden of proof is on the accused and the section sets no quantity threshold. Possession for supply and trafficking: the Act's text states no separate offence of possession for supply or of trafficking for Part III drugs. Sale and distribution: these are left to rules the Minister may make under section 15(1)(b), and the only rules located are the 2025 methylamphetamine rules, so a sale offence for this substance is not verified beyond the general offence in section 39(1)(a) of contravening the Act or a rule under it. Import and export are two separate offences: sections 14, 23, 25, 28 and 30 prohibit them except in accordance with sections 22 to 30, section 3 limits entry and exit to a port approved by notice, and a person exporting in contravention is also liable under section 35(2) to forfeit treble the value of the goods or 2,000 penalty units at the option of the Comptroller of Customs and Excise. Manufacture: section 15(1)(a) lets rules prohibit manufacture except on licensed premises, and the Act's text states no manufacture offence itself. Cultivation: no cultivation offence applies to codeine itself; the plant offences in sections 7 and 8 concern the opium poppy, Indian hemp and coca leaf plants and are not applied to codeine here. Use or consumption: the instruments read state no separate offence of use for Part III drugs, so possession under section 20 is the exposure. Administrative offences: section 39(1)(b) and (c) cover breach of licence conditions and false statements to obtain a licence or authority. Penalty: no penalty is otherwise prescribed, so section 39(2) applies to each offence, namely on conviction by the court sitting with assessors a fine of 100,000 penalty units or imprisonment for ten years or both, and on summary conviction a fine of 5,000 penalty units or imprisonment for six months or both, with forfeiture of all articles in respect of which the offence was committed. Fine and imprisonment may be cumulative ('or to both such fine and imprisonment'). Section 39(4) gives attempting, soliciting and inciting the same punishment, and section 39(3) requires the consent of the Director of Public Prosecutions for proceedings under section 39(1)(a). The Act's drug provisions state no death penalty. The Act does not state the value of a penalty unit and none is converted here. Section 21(1) forbids trade in, or manufacture for trade of, products from the phenanthrene alkaloids of opium that were not in medical or scientific use on 13 July 1931; whether it reaches codeine turns on that 1931 fact, which the instruments read do not give.
If prescribed / medical: The medical route is in the Dangerous Drugs Act itself. Section 15(1)(c) lets the Minister make rules regulating the issue by medical practitioners of prescriptions containing a Part III drug and the dispensing of them, and section 15(2) requires the rules to authorise a pharmaceutical chemist or chemist and druggist to retail, dispense or compound such drugs in the ordinary course of business. Section 19 limits withdrawal from the store to a registered medical practitioner, licensed pharmacist, registered dentist, qualified veterinary surgeon, an approved plantation hospital attendant, or a person approved for recognised Mission medical work. Section 20 treats possession in accordance with the prescription of a registered medical practitioner as a matter the accused may prove. Section 39(3) bars imprisonment without the option of a fine, and caps the fine at 100 penalty units, for an inadvertent breach of the rules on keeping books or on prescriptions. Rules under section 15 other than the 2025 methylamphetamine rules were not located, so the detailed prescription rules for codeine are not verified. The Pharmacy and Poisons Act (Cap. 105, reprint as in force 5 February 2024) also speaks to prescriptions for these drugs in its own text. Section 36(4) reads 'A prescription which does not comply with the provisions of this section shall not be accepted by any pharmacist as authority for the sale or supply of any medicine or drug'. Section 37(2) reads that every prescription 'containing any of the drugs to which any Act as to the sale of dangerous drugs, for the time being in force, relates, shall be retained in the custody of the pharmacist dispensing the same for a period of two years and filed in the pharmacy'. Section 38(c) provides that a pharmacist shall not 'permit any person, other than a registered pharmacist, to dispense or compound any prescription or supply any medicine or drugs containing any of the dangerous drugs to which subsection (2) of section 37 relates'. The Poisons Rules (1996 Revised Edition) add a second route. The Fourth Schedule on printed page 3024 lists 'Codeine; but if: (a) in linctus for treatment of cough ms 0.3% Schedule 1; or (b) in compound analgesic preparations ms 10 mg as phosphate per unit dose, mdd 80 mg Schedule 1'. Rule 11(1) of the Poisons Rules (printed page 3004) reads 'It shall not be lawful to sell any poison included in the Fourth Schedule to these Rules except on and in accordance with the prescription given by a registered medical practitioner, registered dentist or a qualified veterinary surgeon in the form provided by this rule', and rule 11(2) applies the rule to a sale even where it is a transaction exempted by section 57 of the Act. The pages read do not say what 'Schedule 1' means in that entry or what rule then applies, and do not define 'ms' or 'mdd', so which low strength codeine products avoid prescription only sale is not established. The First Schedule (printed page 3013) separately lists 'Codeine, except substances containing less than 0.1 per cent of codeine'. Under rule 11(3) a prescription must be in writing, signed with the usual signature and dated, give the prescriber's address, give the name and address of the person treated, and indicate the total amount to be supplied and the dose to be taken; under rule 11(4) it may not be dispensed more than once unless the prescriber states that it may, and the dispenser must note the seller's name, address and date on it and keep it on the premises for two years. Rule 11 is a sale rule under the Pharmacy and Poisons Act and is separate from the Dangerous Drugs Act control above; section 57 of that Act exempts a medicine supplied by a qualified medical practitioner or dispensed by a registered pharmacist from the poison sale rules only so far as rule 11 does not apply. Whether these Rules are still in force is not established: the copy read is the 1996 Revised Edition (margin notes to LN 63 of 1988), the 2024 reprint of the Act keeps the rule making power in section 61 but does not print the Rules, its endnotes record repeals of sections 16 to 26, 28 to 32 and 35 by Act No. 5 of 1997 and amendments in 2009 and 2023, and nothing read states that the Rules were amended or revoked.
Documentation: Importing codeine as a Part III drug requires an import authorisation in Form C granted by the Permanent Secretary, Ministry of Health and Medical Services under section 26, and section 28 provides that no dangerous drug shall be imported unless the person to whom it is consigned holds a valid and subsisting import authorisation. Section 29 requires an export authorisation or diversion certificate from a country party to the Convention to accompany the drug, and section 31 sets the transit conditions. The only quantity exemption from the transit rules is section 31(5), for quantities that bona fide form part of the medical stores of a ship or aircraft. The sections read state no exemption for a traveller's personal supply, so none is established, and the Convention as defined in section 2 names only the 1912, 1925 and 1931 instruments. Under the Pharmacy and Poisons Act, section 52(1) forbids importing 'any poison' except under a licence issued by the Board, with a proviso for qualified medical practitioners, registered pharmacists, qualified veterinary surgeons or qualified dentists importing for bona fide treatment; the proviso does not mention a traveller. A reported Dangerous Drugs (Amendment) Bill 2025 was not read.

Dangerous Drugs Act (Cap. 98), reprint as in force 1 October 2009, sections 2, 13, 15 and 39 · attorneygenerals.gov.sb · Proclamations LN 101 of 1987 and LN 6 of 1988 applying Part III, as printed in the 1996 Revised Edition, Cap. 98 subsidiary legislation, printed pages 2821 to 2824 · solomon-islands.tradeportal.org · Pharmacy and Poisons Act (Cap. 105), reprint as in force 5 February 2024, sections 36 to 38 and 44 to 62 and Schedule B Poisons List · attorneygenerals.gov.sb · Poisons Rules under the Pharmacy and Poisons Act (Cap. 105), 1996 Revised Edition, printed pages 3000 to 3043, rule 11 and the First and Fourth Schedules · solomon-islands.tradeportal.org · Dangerous Drugs (Methylamphetamine) Rules 2025, Gazette No. 158 of 5 November 2025 · solomons.gov.sb · Updated October 7, 2026

Codeine in Solomon Islands, full detail →

Crack Cocaine

Legal status: Controlled. 'Crack' is not a word used in any instrument read, so the answer rests on the compound. Cocaine is a named Part III drug of the Dangerous Drugs Act (Cap. 98), reprint as in force at 1 October 2009. Section 13(1)(d) applies Part III to 'cocaine (including synthetic cocaine) and ecgonine and their respective salts and the esters of ecgonine and their respective salts', so the compound and its salts are listed separately, and section 2 defines cocaine by a chemical name and formula as the compound itself, not as a salt. The identity is taken from a chemical record and not from any law read: the US National Library of Medicine MeSH concept M0025291 (Crack Cocaine) carries the scope note 'The purified, alkaloidal, extra-potent form of cocaine. It is smoked (free-based), injected intravenously, and orally ingested...', so crack is a form of cocaine and falls within section 13(1)(d). For a street product that is an admixture, section 13(1)(e) separately reaches 'any dilution or solution of morphine or cocaine or their salts in an inert substance, whether liquid or solid, containing any proportion of morphine or cocaine', and 'any preparation, admixture, extract or other substance (not being such a dilution or solution as aforesaid) containing not less than... one-tenth per centum of cocaine or of ecgonine', which applies only where the admixture meets that proportion. The proclamation of 21 September 1987 (LN 101 of 1987) also lists 'Cocaine' on printed page 2821 and 'Ecgonine, and any derivative of ecgonine which is convertible to ecgonine or to cocaine' on printed page 2822. The named entries govern and no generic clause is needed. Schedule B Part I of the Pharmacy and Poisons Act lists 'Cocaine', 'Coca, alkaloids of' and 'Ecgonine; its esters' as poisons, which is a sale restriction and separate from drug control. The coca plant is a separate Part I matter and is not what this answer addresses.
Consequences if caught: Crack as cocaine, a Part III drug: Personal possession: section 20 makes it an offence against the Act when a Part III drug is found in a person's possession or kept in any place other than the appointed store, unless he can prove that it was obtained under the authority of the Act, or in accordance with the prescription of a registered medical practitioner, or from a person having authority to sell it, or was deposited there without his knowledge or consent. The burden of proof is on the accused and the section sets no quantity threshold. Possession for supply and trafficking: the Act's text states no separate offence of possession for supply or of trafficking for Part III drugs. Sale and distribution: these are left to rules the Minister may make under section 15(1)(b), and the only rules located are the 2025 methylamphetamine rules, so a sale offence for this substance is not verified beyond the general offence in section 39(1)(a) of contravening the Act or a rule under it. Import and export are two separate offences: sections 14, 23, 25, 28 and 30 prohibit them except in accordance with sections 22 to 30, section 3 limits entry and exit to a port approved by notice, and a person exporting in contravention is also liable under section 35(2) to forfeit treble the value of the goods or 2,000 penalty units at the option of the Comptroller of Customs and Excise. Manufacture: section 15(1)(a) lets rules prohibit manufacture except on licensed premises, and the Act's text states no manufacture offence itself. Cultivation: the coca leaf plant is a Part I matter and is not crack; section 7 forbids cultivating it, section 8(a) makes growing it an offence 'whether for private use or otherwise', and those Part I offences state no penalty of their own, so section 39(2) applies to them as well. Use or consumption: the instruments read state no separate offence of use for Part III drugs, so possession under section 20 is the exposure. Administrative offences: section 39(1)(b) and (c) cover breach of licence conditions and false statements to obtain a licence or authority. Penalty: no penalty is otherwise prescribed, so section 39(2) applies to each offence, namely on conviction by the court sitting with assessors a fine of 100,000 penalty units or imprisonment for ten years or both, and on summary conviction a fine of 5,000 penalty units or imprisonment for six months or both, with forfeiture of all articles in respect of which the offence was committed. Fine and imprisonment may be cumulative ('or to both such fine and imprisonment'). Section 39(4) gives attempting, soliciting and inciting the same punishment, and section 39(3) requires the consent of the Director of Public Prosecutions for proceedings under section 39(1)(a). The Act's drug provisions state no death penalty. The Act does not state the value of a penalty unit and none is converted here. Section 21(1) forbids trade in, or manufacture for trade of, products from the ecgonine alkaloids of the coca leaf that were not in medical or scientific use on 13 July 1931; whether it reaches crack turns on that 1931 fact, which the instruments read do not give. A smokable form for medical use is not described in any instrument read.
If prescribed / medical: The medical route is in the Dangerous Drugs Act itself. Section 15(1)(c) lets the Minister make rules regulating the issue by medical practitioners of prescriptions containing a Part III drug and the dispensing of them, and section 15(2) requires the rules to authorise a pharmaceutical chemist or chemist and druggist to retail, dispense or compound such drugs in the ordinary course of business. Section 19 limits withdrawal from the store to a registered medical practitioner, licensed pharmacist, registered dentist, qualified veterinary surgeon, an approved plantation hospital attendant, or a person approved for recognised Mission medical work. Section 20 treats possession in accordance with the prescription of a registered medical practitioner as a matter the accused may prove. Section 39(3) bars imprisonment without the option of a fine, and caps the fine at 100 penalty units, for an inadvertent breach of the rules on keeping books or on prescriptions. Rules under section 15 other than the 2025 methylamphetamine rules were not located, so the detailed prescription rules for crack and the cocaine it consists of are not verified. The Pharmacy and Poisons Act (Cap. 105, reprint as in force 5 February 2024) also speaks to prescriptions for these drugs in its own text. Section 36(4) reads 'A prescription which does not comply with the provisions of this section shall not be accepted by any pharmacist as authority for the sale or supply of any medicine or drug'. Section 37(2) reads that every prescription 'containing any of the drugs to which any Act as to the sale of dangerous drugs, for the time being in force, relates, shall be retained in the custody of the pharmacist dispensing the same for a period of two years and filed in the pharmacy'. Section 38(c) provides that a pharmacist shall not 'permit any person, other than a registered pharmacist, to dispense or compound any prescription or supply any medicine or drugs containing any of the dangerous drugs to which subsection (2) of section 37 relates'. The Poisons Rules (1996 Revised Edition) list 'Cocaine' on printed page 3024 and 'Ecgonine' on printed page 3026 in the Fourth Schedule, and rule 11(1) forbids a sale of a Fourth Schedule poison except on a prescription of a registered medical practitioner, registered dentist or qualified veterinary surgeon. Under rule 11(3) a prescription must be in writing, signed with the usual signature and dated, give the prescriber's address, give the name and address of the person treated, and indicate the total amount to be supplied and the dose to be taken; under rule 11(4) it may not be dispensed more than once unless the prescriber states that it may, and the dispenser must note the seller's name, address and date on it and keep it on the premises for two years. The Poisons List in Schedule B Part I of the Pharmacy and Poisons Act also lists 'Cocaine', which restricts retail sale to authorised sellers (section 56(1)(a), (2)); that is a pharmacy sale control and is separate from the drug control above. Current force is the open point for this Fourth Schedule entry. The Rules were read in the 1996 Revised Edition only. The 2024 reprint of the Act has section 61 (rules) and endnotes showing repeals by Act No. 5 of 1997 and amendments in 2009 and 2023, does not print the Rules, and nothing read says they were amended or revoked.
Documentation: Importing crack as a Part III drug requires an import authorisation in Form C granted by the Permanent Secretary, Ministry of Health and Medical Services under section 26, and section 28 provides that no dangerous drug shall be imported unless the person to whom it is consigned holds a valid and subsisting import authorisation. Section 29 requires an export authorisation or diversion certificate from a country party to the Convention to accompany the drug, and section 31 sets the transit conditions. The only quantity exemption from the transit rules is section 31(5), for quantities that bona fide form part of the medical stores of a ship or aircraft. The sections read state no exemption for a traveller's personal supply, so none is established, and the Convention as defined in section 2 names only the 1912, 1925 and 1931 instruments. Coca leaf and coca seed are Part I substances, and sections 4(2) and 5 prohibit their import and export without stating any authorisation route. A reported Dangerous Drugs (Amendment) Bill 2025 was not read.

Dangerous Drugs Act (Cap. 98), reprint as in force 1 October 2009, sections 2, 13, 15 and 39 · attorneygenerals.gov.sb · Proclamations LN 101 of 1987 and LN 6 of 1988 applying Part III, as printed in the 1996 Revised Edition, Cap. 98 subsidiary legislation, printed pages 2821 to 2824 · solomon-islands.tradeportal.org · Pharmacy and Poisons Act (Cap. 105), reprint as in force 5 February 2024, sections 36 to 38 and 44 to 62 and Schedule B Poisons List · attorneygenerals.gov.sb · Poisons Rules under the Pharmacy and Poisons Act (Cap. 105), 1996 Revised Edition, printed pages 3000 to 3043, rule 11 and the Fourth Schedule · solomon-islands.tradeportal.org · Dangerous Drugs (Methylamphetamine) Rules 2025, Gazette No. 158 of 5 November 2025 · solomons.gov.sb · Chemical identity source, cited as an identity record and not as law: NLM MeSH concept M0025291, Crack Cocaine, scope note 'The purified, alkaloidal, extra-potent form of cocaine. It is smoked (free-based), injected intravenously, and orally ingested...' · id.nlm.nih.gov · Updated October 7, 2026

Crack Cocaine in Solomon Islands, full detail →

Fentanyl

Legal status: Controlled. Fentanyl is a named drug in the proclamation of 21 September 1987 (LN 101 of 1987) applying Part III of the Dangerous Drugs Act (Cap. 98, reprint as in force at 1 October 2009) under section 13(2). Paragraph 1 of the schedule, printed page 2822 of the 1996 Revised Edition, lists 'Fentanyl', between 'Etoxeridine' and 'Furethidine'. 'Sufentanil' is a separate entry on the same page and is not the answer for fentanyl. Paragraph 2 extends Part III to any stereoisomeric form of a paragraph 1 substance, paragraph 3 to esters and ethers, paragraph 4 to salts and paragraph 5 to preparations. Paragraph 5 of the 1987 schedule (and paragraph 9 for the second list) reaches 'any preparations or other product containing a substance' of the earlier paragraphs but excludes 'a preparation specified in Schedule 1'; no Schedule 1 appears in the pages read and no order under section 13(3) was read, so which preparations are outside the control is not established. LN 6 of 1988 paragraphs (d) and (h) (printed page 2824) refer instead to 'the Schedule to the Proclamation referred to in paragraph (a)', so 'Schedule 1' in LN 101 paragraphs 5 and 9 may mean the paragraph 1 list of that Schedule; no instrument read states that reading. Analogues of fentanyl that are not printed in the schedule are not claimed here; only the named entry and its salts, stereoisomers, esters, ethers and preparations are. The named entry governs and no generic clause is needed. The Poisons List in Schedule B of the Pharmacy and Poisons Act does not name fentanyl.
Consequences if caught: Fentanyl as a Part III drug through the proclamation: Personal possession: section 20 makes it an offence against the Act when a Part III drug is found in a person's possession or kept in any place other than the appointed store, unless he can prove that it was obtained under the authority of the Act, or in accordance with the prescription of a registered medical practitioner, or from a person having authority to sell it, or was deposited there without his knowledge or consent. The burden of proof is on the accused and the section sets no quantity threshold. Possession for supply and trafficking: the Act's text states no separate offence of possession for supply or of trafficking for Part III drugs. Sale and distribution: these are left to rules the Minister may make under section 15(1)(b), and the only rules located are the 2025 methylamphetamine rules, so a sale offence for this substance is not verified beyond the general offence in section 39(1)(a) of contravening the Act or a rule under it. Import and export are two separate offences: sections 14, 23, 25, 28 and 30 prohibit them except in accordance with sections 22 to 30, section 3 limits entry and exit to a port approved by notice, and a person exporting in contravention is also liable under section 35(2) to forfeit treble the value of the goods or 2,000 penalty units at the option of the Comptroller of Customs and Excise. Manufacture: section 15(1)(a) lets rules prohibit manufacture except on licensed premises, and the Act's text states no manufacture offence itself. Cultivation: fentanyl is synthetic and no cultivation offence applies to it. Use or consumption: the instruments read state no separate offence of use for Part III drugs, so possession under section 20 is the exposure. Administrative offences: section 39(1)(b) and (c) cover breach of licence conditions and false statements to obtain a licence or authority. Penalty: no penalty is otherwise prescribed, so section 39(2) applies to each offence, namely on conviction by the court sitting with assessors a fine of 100,000 penalty units or imprisonment for ten years or both, and on summary conviction a fine of 5,000 penalty units or imprisonment for six months or both, with forfeiture of all articles in respect of which the offence was committed. Fine and imprisonment may be cumulative ('or to both such fine and imprisonment'). Section 39(4) gives attempting, soliciting and inciting the same punishment, and section 39(3) requires the consent of the Director of Public Prosecutions for proceedings under section 39(1)(a). The Act's drug provisions state no death penalty. The Act does not state the value of a penalty unit and none is converted here.
If prescribed / medical: The medical route is in the Dangerous Drugs Act itself. Section 15(1)(c) lets the Minister make rules regulating the issue by medical practitioners of prescriptions containing a Part III drug and the dispensing of them, and section 15(2) requires the rules to authorise a pharmaceutical chemist or chemist and druggist to retail, dispense or compound such drugs in the ordinary course of business. Section 19 limits withdrawal from the store to a registered medical practitioner, licensed pharmacist, registered dentist, qualified veterinary surgeon, an approved plantation hospital attendant, or a person approved for recognised Mission medical work. Section 20 treats possession in accordance with the prescription of a registered medical practitioner as a matter the accused may prove. Section 39(3) bars imprisonment without the option of a fine, and caps the fine at 100 penalty units, for an inadvertent breach of the rules on keeping books or on prescriptions. Rules under section 15 other than the 2025 methylamphetamine rules were not located, so the detailed prescription rules for fentanyl are not verified. The Pharmacy and Poisons Act (Cap. 105, reprint as in force 5 February 2024) also speaks to prescriptions for these drugs in its own text. Section 36(4) reads 'A prescription which does not comply with the provisions of this section shall not be accepted by any pharmacist as authority for the sale or supply of any medicine or drug'. Section 37(2) reads that every prescription 'containing any of the drugs to which any Act as to the sale of dangerous drugs, for the time being in force, relates, shall be retained in the custody of the pharmacist dispensing the same for a period of two years and filed in the pharmacy'. Section 38(c) provides that a pharmacist shall not 'permit any person, other than a registered pharmacist, to dispense or compound any prescription or supply any medicine or drugs containing any of the dangerous drugs to which subsection (2) of section 37 relates'. The Fourth Schedule to the Poisons Rules (1996 Revised Edition, printed pages 3019 to 3042) was read from the page images and does not list fentanyl by name; it does list 'Sufentanil' (page 3040), a different substance. So rule 11, which forbids sale of a Fourth Schedule poison except on prescription, is not shown to reach fentanyl, and the medical route for fentanyl rests on the Dangerous Drugs Act provisions above. Whether other poisons rules or a later amendment add it is not established.
Documentation: Importing fentanyl as a Part III drug requires an import authorisation in Form C granted by the Permanent Secretary, Ministry of Health and Medical Services under section 26, and section 28 provides that no dangerous drug shall be imported unless the person to whom it is consigned holds a valid and subsisting import authorisation. Section 29 requires an export authorisation or diversion certificate from a country party to the Convention to accompany the drug, and section 31 sets the transit conditions. The only quantity exemption from the transit rules is section 31(5), for quantities that bona fide form part of the medical stores of a ship or aircraft. The sections read state no exemption for a traveller's personal supply, so none is established, and the Convention as defined in section 2 names only the 1912, 1925 and 1931 instruments. The Poisons List (Schedule B) and the Fourth Schedule do not name fentanyl, so no poisons licence provision is shown to apply to its import. A reported Dangerous Drugs (Amendment) Bill 2025 was not read.

Dangerous Drugs Act (Cap. 98), reprint as in force 1 October 2009, sections 2, 13, 15 and 39 · attorneygenerals.gov.sb · Proclamations LN 101 of 1987 and LN 6 of 1988 applying Part III, as printed in the 1996 Revised Edition, Cap. 98 subsidiary legislation, printed pages 2821 to 2824 · solomon-islands.tradeportal.org · Pharmacy and Poisons Act (Cap. 105), reprint as in force 5 February 2024, sections 36 to 38 and 44 to 62 and Schedule B Poisons List · attorneygenerals.gov.sb · Poisons Rules under the Pharmacy and Poisons Act (Cap. 105), 1996 Revised Edition, printed pages 3000 to 3043, rule 11 and the Fourth Schedule · solomon-islands.tradeportal.org · Dangerous Drugs (Methylamphetamine) Rules 2025, Gazette No. 158 of 5 November 2025 · solomons.gov.sb · Updated October 7, 2026

Fentanyl in Solomon Islands, full detail →

Heroin

Legal status: Controlled. Heroin is named in the Dangerous Drugs Act (Cap. 98), reprint as in force at 1 October 2009, itself. Section 2 defines 'diacetylmorphine' as 'the diacetylmorphine (diamorphone, heroin)' with its formula, section 13(1)(c) applies Part III to 'morphine and its salts and diacetylmorphine (commonly known as diamorphine or heroin) and the other esters of morphine and their respective salts', and section 13(1)(f) applies it to 'any preparation, admixture, extract or other substance containing any proportion of diacetylmorphine', so no strength threshold applies to a heroin mixture. The proclamation of 21 September 1987 (LN 101 of 1987), printed page 2821, also lists 'Diacetylmorphine' and 'Diamorphine' in paragraph 1, and 'Morphine' on page 2822. The statutory limbs stand without the proclamation, so the preparation exemption in paragraph 5 ('not being a preparation specified in Schedule 1', no such Schedule 1 being in the pages read) does not narrow section 13(1)(f). LN 6 of 1988 paragraphs (d) and (h) (printed page 2824) refer instead to 'the Schedule to the Proclamation referred to in paragraph (a)', so 'Schedule 1' in LN 101 paragraphs 5 and 9 may mean the paragraph 1 list of that Schedule; no instrument read states that reading. Named entries govern and no generic clause is needed. Schedule B Part I of the Pharmacy and Poisons Act lists 'Diacetylmorphine' among the alkaloids as a poison, which is a sale restriction and separate from drug control.
Consequences if caught: Heroin as a Part III drug: Personal possession: section 20 makes it an offence against the Act when a Part III drug is found in a person's possession or kept in any place other than the appointed store, unless he can prove that it was obtained under the authority of the Act, or in accordance with the prescription of a registered medical practitioner, or from a person having authority to sell it, or was deposited there without his knowledge or consent. The burden of proof is on the accused and the section sets no quantity threshold. Possession for supply and trafficking: the Act's text states no separate offence of possession for supply or of trafficking for Part III drugs. Sale and distribution: these are left to rules the Minister may make under section 15(1)(b), and the only rules located are the 2025 methylamphetamine rules, so a sale offence for this substance is not verified beyond the general offence in section 39(1)(a) of contravening the Act or a rule under it. Import and export are two separate offences: sections 14, 23, 25, 28 and 30 prohibit them except in accordance with sections 22 to 30, section 3 limits entry and exit to a port approved by notice, and a person exporting in contravention is also liable under section 35(2) to forfeit treble the value of the goods or 2,000 penalty units at the option of the Comptroller of Customs and Excise. Manufacture: section 15(1)(a) lets rules prohibit manufacture except on licensed premises, and the Act's text states no manufacture offence itself. Cultivation: heroin is not a plant; the opium poppy is a Part I matter, and section 7 forbids cultivating it while section 8(a) makes growing it an offence 'whether for private use or otherwise'. Use or consumption: the instruments read state no separate offence of use for Part III drugs, so possession under section 20 is the exposure. Administrative offences: section 39(1)(b) and (c) cover breach of licence conditions and false statements to obtain a licence or authority. Penalty: no penalty is otherwise prescribed, so section 39(2) applies to each offence, namely on conviction by the court sitting with assessors a fine of 100,000 penalty units or imprisonment for ten years or both, and on summary conviction a fine of 5,000 penalty units or imprisonment for six months or both, with forfeiture of all articles in respect of which the offence was committed. Fine and imprisonment may be cumulative ('or to both such fine and imprisonment'). Section 39(4) gives attempting, soliciting and inciting the same punishment, and section 39(3) requires the consent of the Director of Public Prosecutions for proceedings under section 39(1)(a). The Act's drug provisions state no death penalty. The Act does not state the value of a penalty unit and none is converted here. Section 21(1) forbids trade in, or manufacture for trade of, products from the phenanthrene alkaloids of opium that were not in medical or scientific use on 13 July 1931; heroin is named in section 13(1) so the named entries and sections 20 and 39 are the working provisions, and section 21(1) is not needed for the answer.
If prescribed / medical: The medical route is in the Dangerous Drugs Act itself. Section 15(1)(c) lets the Minister make rules regulating the issue by medical practitioners of prescriptions containing a Part III drug and the dispensing of them, and section 15(2) requires the rules to authorise a pharmaceutical chemist or chemist and druggist to retail, dispense or compound such drugs in the ordinary course of business. Section 19 limits withdrawal from the store to a registered medical practitioner, licensed pharmacist, registered dentist, qualified veterinary surgeon, an approved plantation hospital attendant, or a person approved for recognised Mission medical work. Section 20 treats possession in accordance with the prescription of a registered medical practitioner as a matter the accused may prove. Section 39(3) bars imprisonment without the option of a fine, and caps the fine at 100 penalty units, for an inadvertent breach of the rules on keeping books or on prescriptions. Rules under section 15 other than the 2025 methylamphetamine rules were not located, so the detailed prescription rules for heroin are not verified. The Pharmacy and Poisons Act (Cap. 105, reprint as in force 5 February 2024) also speaks to prescriptions for these drugs in its own text. Section 36(4) reads 'A prescription which does not comply with the provisions of this section shall not be accepted by any pharmacist as authority for the sale or supply of any medicine or drug'. Section 37(2) reads that every prescription 'containing any of the drugs to which any Act as to the sale of dangerous drugs, for the time being in force, relates, shall be retained in the custody of the pharmacist dispensing the same for a period of two years and filed in the pharmacy'. Section 38(c) provides that a pharmacist shall not 'permit any person, other than a registered pharmacist, to dispense or compound any prescription or supply any medicine or drugs containing any of the dangerous drugs to which subsection (2) of section 37 relates'. The Poisons Rules (1996 Revised Edition) list 'Diacetylmorphine' and 'Diamorphine' on printed page 3025 in the Fourth Schedule, and rule 11(1) forbids a sale of a Fourth Schedule poison except on a prescription of a registered medical practitioner, registered dentist or qualified veterinary surgeon. Under rule 11(3) a prescription must be in writing, signed with the usual signature and dated, give the prescriber's address, give the name and address of the person treated, and indicate the total amount to be supplied and the dose to be taken; under rule 11(4) it may not be dispensed more than once unless the prescriber states that it may, and the dispenser must note the seller's name, address and date on it and keep it on the premises for two years. That is a pharmacy sale control and is separate from the drug control above. No instrument read describes a medical heroin product in use in Solomon Islands. Current force is the open point for this Fourth Schedule entry. The Rules were read in the 1996 Revised Edition only. The 2024 reprint of the Act has section 61 (rules) and endnotes showing repeals by Act No. 5 of 1997 and amendments in 2009 and 2023, does not print the Rules, and nothing read says they were amended or revoked.
Documentation: Importing heroin as a Part III drug requires an import authorisation in Form C granted by the Permanent Secretary, Ministry of Health and Medical Services under section 26, and section 28 provides that no dangerous drug shall be imported unless the person to whom it is consigned holds a valid and subsisting import authorisation. Section 29 requires an export authorisation or diversion certificate from a country party to the Convention to accompany the drug, and section 31 sets the transit conditions. The only quantity exemption from the transit rules is section 31(5), for quantities that bona fide form part of the medical stores of a ship or aircraft. The sections read state no exemption for a traveller's personal supply, so none is established, and the Convention as defined in section 2 names only the 1912, 1925 and 1931 instruments. Under the Pharmacy and Poisons Act, section 52(1) forbids importing 'any poison' except under a licence issued by the Board, with a proviso for qualified medical practitioners, registered pharmacists, qualified veterinary surgeons or qualified dentists importing for bona fide treatment; the proviso does not mention a traveller. A reported Dangerous Drugs (Amendment) Bill 2025 was not read.

Dangerous Drugs Act (Cap. 98), reprint as in force 1 October 2009, sections 2, 13, 15 and 39 · attorneygenerals.gov.sb · Proclamations LN 101 of 1987 and LN 6 of 1988 applying Part III, as printed in the 1996 Revised Edition, Cap. 98 subsidiary legislation, printed pages 2821 to 2824 · solomon-islands.tradeportal.org · Pharmacy and Poisons Act (Cap. 105), reprint as in force 5 February 2024, sections 36 to 38 and 44 to 62 and Schedule B Poisons List · attorneygenerals.gov.sb · Poisons Rules under the Pharmacy and Poisons Act (Cap. 105), 1996 Revised Edition, printed pages 3000 to 3043, rule 11 and the Fourth Schedule · solomon-islands.tradeportal.org · Dangerous Drugs (Methylamphetamine) Rules 2025, Gazette No. 158 of 5 November 2025 · solomons.gov.sb · Updated October 7, 2026

Heroin in Solomon Islands, full detail →

Hydrocodone

Legal status: Controlled. Hydrocodone is a named drug in the proclamation of 21 September 1987 (LN 101 of 1987) applying Part III of the Dangerous Drugs Act (Cap. 98, reprint as in force at 1 October 2009) under section 13(2). Paragraph 1 of the schedule, printed page 2822 of the 1996 Revised Edition, lists 'Hydrocodone', between 'Furethidine' and 'Hydromorphinol'. Nearby entries are different names and are not the answer: 'Acethydrocodone' (page 2821) and 'Dihydrocodeinone O-carboxymethyloxime' (page 2821) are separate entries. Section 13(1)(g) of the Act separately lists 'dihydrocodeinone' and 'acetyldihydrocodeinone'; the instruments do not state that dihydrocodeinone is the same compound as hydrocodone, so this reading rests on the printed name 'Hydrocodone' alone. Paragraph 2 extends Part III to any stereoisomeric form of a paragraph 1 substance (not dextromethorphan or dextrorphan), paragraph 3 to esters and ethers, paragraph 4 to salts and paragraph 5 to preparations. Paragraph 5 of the 1987 schedule (and paragraph 9 for the second list) reaches 'any preparations or other product containing a substance' of the earlier paragraphs but excludes 'a preparation specified in Schedule 1'; no Schedule 1 appears in the pages read and no order under section 13(3) was read, so which preparations are outside the control is not established. LN 6 of 1988 paragraphs (d) and (h) (printed page 2824) refer instead to 'the Schedule to the Proclamation referred to in paragraph (a)', so 'Schedule 1' in LN 101 paragraphs 5 and 9 may mean the paragraph 1 list of that Schedule; no instrument read states that reading. The named entry governs and no generic clause is needed. The Poisons List in Schedule B Part I of the Pharmacy and Poisons Act does not name 'Hydrocodone', but it names 'Dihydrocodeinone; its esters.' among the alkaloids; that entry is not relied on here and the verdict stays on the named Act and proclamation entries. Section 21(1) of the Act, which bars trade in products obtained from the phenanthrene alkaloids of opium that were not in medical or scientific use on 13 July 1931 unless the Minister proclaims otherwise, is not applied: the instruments read do not say whether hydrocodone is such a product, and the named proclamation entry is the basis.
Consequences if caught: Hydrocodone as a Part III drug through the proclamation: Personal possession: section 20 makes it an offence against the Act when a Part III drug is found in a person's possession or kept in any place other than the appointed store, unless he can prove that it was obtained under the authority of the Act, or in accordance with the prescription of a registered medical practitioner, or from a person having authority to sell it, or was deposited there without his knowledge or consent. The burden of proof is on the accused and the section sets no quantity threshold. Possession for supply and trafficking: the Act's text states no separate offence of possession for supply or of trafficking for Part III drugs. Sale and distribution: these are left to rules the Minister may make under section 15(1)(b), and the only rules located are the 2025 methylamphetamine rules, so a sale offence for this substance is not verified beyond the general offence in section 39(1)(a) of contravening the Act or a rule under it. Import and export are two separate offences: sections 14, 23, 25, 28 and 30 prohibit them except in accordance with sections 22 to 30, section 3 limits entry and exit to a port approved by notice, and a person exporting in contravention is also liable under section 35(2) to forfeit treble the value of the goods or 2,000 penalty units at the option of the Comptroller of Customs and Excise. Manufacture: section 15(1)(a) lets rules prohibit manufacture except on licensed premises, and the Act's text states no manufacture offence itself. Cultivation: no cultivation offence applies to hydrocodone; the plant offences in sections 7 and 8 concern the opium poppy, Indian hemp and coca leaf plants. Use or consumption: the instruments read state no separate offence of use for Part III drugs, so possession under section 20 is the exposure. Administrative offences: section 39(1)(b) and (c) cover breach of licence conditions and false statements to obtain a licence or authority. Penalty: no penalty is otherwise prescribed, so section 39(2) applies to each offence, namely on conviction by the court sitting with assessors a fine of 100,000 penalty units or imprisonment for ten years or both, and on summary conviction a fine of 5,000 penalty units or imprisonment for six months or both, with forfeiture of all articles in respect of which the offence was committed. Fine and imprisonment may be cumulative ('or to both such fine and imprisonment'). Section 39(4) gives attempting, soliciting and inciting the same punishment, and section 39(3) requires the consent of the Director of Public Prosecutions for proceedings under section 39(1)(a). The Act's drug provisions state no death penalty. The Act does not state the value of a penalty unit and none is converted here.
If prescribed / medical: The medical route is in the Dangerous Drugs Act itself. Section 15(1)(c) lets the Minister make rules regulating the issue by medical practitioners of prescriptions containing a Part III drug and the dispensing of them, and section 15(2) requires the rules to authorise a pharmaceutical chemist or chemist and druggist to retail, dispense or compound such drugs in the ordinary course of business. Section 19 limits withdrawal from the store to a registered medical practitioner, licensed pharmacist, registered dentist, qualified veterinary surgeon, an approved plantation hospital attendant, or a person approved for recognised Mission medical work. Section 20 treats possession in accordance with the prescription of a registered medical practitioner as a matter the accused may prove. Section 39(3) bars imprisonment without the option of a fine, and caps the fine at 100 penalty units, for an inadvertent breach of the rules on keeping books or on prescriptions. Rules under section 15 other than the 2025 methylamphetamine rules were not located, so the detailed prescription rules for hydrocodone are not verified. The Pharmacy and Poisons Act (Cap. 105, reprint as in force 5 February 2024) also speaks to prescriptions for these drugs in its own text. Section 36(4) reads 'A prescription which does not comply with the provisions of this section shall not be accepted by any pharmacist as authority for the sale or supply of any medicine or drug'. Section 37(2) reads that every prescription 'containing any of the drugs to which any Act as to the sale of dangerous drugs, for the time being in force, relates, shall be retained in the custody of the pharmacist dispensing the same for a period of two years and filed in the pharmacy'. Section 38(c) provides that a pharmacist shall not 'permit any person, other than a registered pharmacist, to dispense or compound any prescription or supply any medicine or drugs containing any of the dangerous drugs to which subsection (2) of section 37 relates'. The Poisons Rules (1996 Revised Edition) list 'Hydrocodone' on printed page 3029 in the Fourth Schedule, and rule 11(1) forbids a sale of a Fourth Schedule poison except on a prescription of a registered medical practitioner, registered dentist or qualified veterinary surgeon. Under rule 11(3) a prescription must be in writing, signed with the usual signature and dated, give the prescriber's address, give the name and address of the person treated, and indicate the total amount to be supplied and the dose to be taken; under rule 11(4) it may not be dispensed more than once unless the prescriber states that it may, and the dispenser must note the seller's name, address and date on it and keep it on the premises for two years. That is a pharmacy sale control and is separate from the drug control above. Whether these Rules are still in force is not established: the copy read is the 1996 Revised Edition (margin notes to LN 63 of 1988), the 2024 reprint of the Act keeps the rule making power in section 61 but does not print the Rules, its endnotes record repeals of sections 16 to 26, 28 to 32 and 35 by Act No. 5 of 1997 and amendments in 2009 and 2023, and nothing read states that the Rules were amended or revoked.
Documentation: Importing hydrocodone as a Part III drug requires an import authorisation in Form C granted by the Permanent Secretary, Ministry of Health and Medical Services under section 26, and section 28 provides that no dangerous drug shall be imported unless the person to whom it is consigned holds a valid and subsisting import authorisation. Section 29 requires an export authorisation or diversion certificate from a country party to the Convention to accompany the drug, and section 31 sets the transit conditions. The only quantity exemption from the transit rules is section 31(5), for quantities that bona fide form part of the medical stores of a ship or aircraft. The sections read state no exemption for a traveller's personal supply, so none is established, and the Convention as defined in section 2 names only the 1912, 1925 and 1931 instruments. Under the Pharmacy and Poisons Act, section 52(1) forbids importing 'any poison' except under a licence issued by the Board, with a proviso for qualified medical practitioners, registered pharmacists, qualified veterinary surgeons or qualified dentists importing for bona fide treatment, and section 2 of the Act reads 'poison includes the several substances mentioned in the poisons list in Schedule B', and nothing mentions a traveller. A reported Dangerous Drugs (Amendment) Bill 2025 was not read.

Dangerous Drugs Act (Cap. 98), reprint as in force 1 October 2009, sections 2, 13, 15 and 39 · attorneygenerals.gov.sb · Proclamations LN 101 of 1987 and LN 6 of 1988 applying Part III, as printed in the 1996 Revised Edition, Cap. 98 subsidiary legislation, printed pages 2821 to 2824 · solomon-islands.tradeportal.org · Pharmacy and Poisons Act (Cap. 105), reprint as in force 5 February 2024, sections 36 to 38 and 44 to 62 and Schedule B Poisons List · attorneygenerals.gov.sb · Poisons Rules under the Pharmacy and Poisons Act (Cap. 105), 1996 Revised Edition, printed pages 3000 to 3043, rule 11 and the Fourth Schedule · solomon-islands.tradeportal.org · Dangerous Drugs (Methylamphetamine) Rules 2025, Gazette No. 158 of 5 November 2025 · solomons.gov.sb · Updated October 7, 2026

Hydrocodone in Solomon Islands, full detail →

Methadone

Legal status: Controlled. Methadone is a named drug in the proclamation of 21 September 1987 (LN 101 of 1987) applying Part III of the Dangerous Drugs Act (Cap. 98, reprint as in force at 1 October 2009) under section 13(2). Paragraph 1 of the schedule, printed page 2822 of the 1996 Revised Edition, lists 'Methadone', between 'Metazocine' and 'Methadyl acetate' (printed 'Methadyl acelate'). Related names are separate entries and are not the answer for methadone itself: 'Isomethadone', 'Normethadone', 'Acetylmethadol', 'Alphacetylmethadol', 'Betacetylmethadol', 'Alphamethadol', 'Betamethadol', 'Noracymethadol', and the unlabelled entry '4-Cyano-2-dimethylamino-4,4-diphenylbutane' printed at the foot of the list. The instruments do not say what that last entry is, and no claim is made about it here. Paragraph 2 extends Part III to any stereoisomeric form of a paragraph 1 substance, paragraph 3 to esters and ethers, paragraph 4 to salts and paragraph 5 to preparations. Paragraph 5 of the 1987 schedule (and paragraph 9 for the second list) reaches 'any preparations or other product containing a substance' of the earlier paragraphs but excludes 'a preparation specified in Schedule 1'; no Schedule 1 appears in the pages read and no order under section 13(3) was read, so which preparations are outside the control is not established. LN 6 of 1988 paragraphs (d) and (h) (printed page 2824) refer instead to 'the Schedule to the Proclamation referred to in paragraph (a)', so 'Schedule 1' in LN 101 paragraphs 5 and 9 may mean the paragraph 1 list of that Schedule; no instrument read states that reading. The named entry governs and no generic clause is needed. The Poisons List in Schedule B of the Pharmacy and Poisons Act does not name methadone.
Consequences if caught: Methadone as a Part III drug through the proclamation: Personal possession: section 20 makes it an offence against the Act when a Part III drug is found in a person's possession or kept in any place other than the appointed store, unless he can prove that it was obtained under the authority of the Act, or in accordance with the prescription of a registered medical practitioner, or from a person having authority to sell it, or was deposited there without his knowledge or consent. The burden of proof is on the accused and the section sets no quantity threshold. Possession for supply and trafficking: the Act's text states no separate offence of possession for supply or of trafficking for Part III drugs. Sale and distribution: these are left to rules the Minister may make under section 15(1)(b), and the only rules located are the 2025 methylamphetamine rules, so a sale offence for this substance is not verified beyond the general offence in section 39(1)(a) of contravening the Act or a rule under it. Import and export are two separate offences: sections 14, 23, 25, 28 and 30 prohibit them except in accordance with sections 22 to 30, section 3 limits entry and exit to a port approved by notice, and a person exporting in contravention is also liable under section 35(2) to forfeit treble the value of the goods or 2,000 penalty units at the option of the Comptroller of Customs and Excise. Manufacture: section 15(1)(a) lets rules prohibit manufacture except on licensed premises, and the Act's text states no manufacture offence itself. Cultivation: methadone is synthetic and no cultivation offence applies to it. Use or consumption: the instruments read state no separate offence of use for Part III drugs, so possession under section 20 is the exposure. Administrative offences: section 39(1)(b) and (c) cover breach of licence conditions and false statements to obtain a licence or authority. Penalty: no penalty is otherwise prescribed, so section 39(2) applies to each offence, namely on conviction by the court sitting with assessors a fine of 100,000 penalty units or imprisonment for ten years or both, and on summary conviction a fine of 5,000 penalty units or imprisonment for six months or both, with forfeiture of all articles in respect of which the offence was committed. Fine and imprisonment may be cumulative ('or to both such fine and imprisonment'). Section 39(4) gives attempting, soliciting and inciting the same punishment, and section 39(3) requires the consent of the Director of Public Prosecutions for proceedings under section 39(1)(a). The Act's drug provisions state no death penalty. The Act does not state the value of a penalty unit and none is converted here.
If prescribed / medical: The medical route is in the Dangerous Drugs Act itself. Section 15(1)(c) lets the Minister make rules regulating the issue by medical practitioners of prescriptions containing a Part III drug and the dispensing of them, and section 15(2) requires the rules to authorise a pharmaceutical chemist or chemist and druggist to retail, dispense or compound such drugs in the ordinary course of business. Section 19 limits withdrawal from the store to a registered medical practitioner, licensed pharmacist, registered dentist, qualified veterinary surgeon, an approved plantation hospital attendant, or a person approved for recognised Mission medical work. Section 20 treats possession in accordance with the prescription of a registered medical practitioner as a matter the accused may prove. Section 39(3) bars imprisonment without the option of a fine, and caps the fine at 100 penalty units, for an inadvertent breach of the rules on keeping books or on prescriptions. Rules under section 15 other than the 2025 methylamphetamine rules were not located, so the detailed prescription rules for methadone are not verified. The Pharmacy and Poisons Act (Cap. 105, reprint as in force 5 February 2024) also speaks to prescriptions for these drugs in its own text. Section 36(4) reads 'A prescription which does not comply with the provisions of this section shall not be accepted by any pharmacist as authority for the sale or supply of any medicine or drug'. Section 37(2) reads that every prescription 'containing any of the drugs to which any Act as to the sale of dangerous drugs, for the time being in force, relates, shall be retained in the custody of the pharmacist dispensing the same for a period of two years and filed in the pharmacy'. Section 38(c) provides that a pharmacist shall not 'permit any person, other than a registered pharmacist, to dispense or compound any prescription or supply any medicine or drugs containing any of the dangerous drugs to which subsection (2) of section 37 relates'. The Poisons Rules (1996 Revised Edition) list 'Methadone' on printed page 3033 in the Fourth Schedule, and rule 11(1) forbids a sale of a Fourth Schedule poison except on a prescription of a registered medical practitioner, registered dentist or qualified veterinary surgeon. Under rule 11(3) a prescription must be in writing, signed with the usual signature and dated, give the prescriber's address, give the name and address of the person treated, and indicate the total amount to be supplied and the dose to be taken; under rule 11(4) it may not be dispensed more than once unless the prescriber states that it may, and the dispenser must note the seller's name, address and date on it and keep it on the premises for two years. That is a pharmacy sale control and is separate from the drug control above. No instrument read describes a methadone maintenance programme. The Poisons Rules were read as printed in the 1996 Revised Edition, whose margin notes run to LN 63 of 1988. The 2024 reprint of the Pharmacy and Poisons Act still carries section 61, the power to make rules, and its endnotes show sections 16 to 26, 28 to 32 and 35 repealed by Act No. 5 of 1997 and other sections amended in 2009 and 2023, but the reprint does not print the Rules and nothing read says they were amended or revoked, so the current force of rule 11 and the Fourth Schedule is not established.
Documentation: Importing methadone as a Part III drug requires an import authorisation in Form C granted by the Permanent Secretary, Ministry of Health and Medical Services under section 26, and section 28 provides that no dangerous drug shall be imported unless the person to whom it is consigned holds a valid and subsisting import authorisation. Section 29 requires an export authorisation or diversion certificate from a country party to the Convention to accompany the drug, and section 31 sets the transit conditions. The only quantity exemption from the transit rules is section 31(5), for quantities that bona fide form part of the medical stores of a ship or aircraft. The sections read state no exemption for a traveller's personal supply, so none is established, and the Convention as defined in section 2 names only the 1912, 1925 and 1931 instruments. Under the Pharmacy and Poisons Act, section 52(1) forbids importing 'any poison' except under a licence issued by the Board, with a proviso for qualified medical practitioners, registered pharmacists, qualified veterinary surgeons or qualified dentists importing for bona fide treatment, and section 2 of the Act reads 'poison includes the several substances mentioned in the poisons list in Schedule B', and nothing mentions a traveller. A reported Dangerous Drugs (Amendment) Bill 2025 was not read.

Dangerous Drugs Act (Cap. 98), reprint as in force 1 October 2009, sections 2, 13, 15 and 39 · attorneygenerals.gov.sb · Proclamations LN 101 of 1987 and LN 6 of 1988 applying Part III, as printed in the 1996 Revised Edition, Cap. 98 subsidiary legislation, printed pages 2821 to 2824 · solomon-islands.tradeportal.org · Pharmacy and Poisons Act (Cap. 105), reprint as in force 5 February 2024, sections 36 to 38 and 44 to 62 and Schedule B Poisons List · attorneygenerals.gov.sb · Poisons Rules under the Pharmacy and Poisons Act (Cap. 105), 1996 Revised Edition, printed pages 3000 to 3043, rule 11 and the Fourth Schedule · solomon-islands.tradeportal.org · Dangerous Drugs (Methylamphetamine) Rules 2025, Gazette No. 158 of 5 November 2025 · solomons.gov.sb · Updated October 7, 2026

Methadone in Solomon Islands, full detail →

Methamphetamine

Legal status: Controlled. The instruments use the name 'Methylamphetamine' and never 'methamphetamine'. The two names are one compound according to a chemical record and not according to any law read: the US National Library of Medicine MeSH concept M0013551 (descriptor D008694, Methamphetamine) lists Methylamphetamine (term T025862) and Metamfetamine (term T025864) as terms. Methylamphetamine is named in the schedule to the proclamation of 21 September 1987 (LN 101 of 1987) that applies Part III of the Dangerous Drugs Act (Cap. 98, reprint as in force 1 October 2009) under section 13(2): paragraph 1, printed page 2822, lists 'Methylamphetamine'. It is listed again in paragraph 6 on page 2823 and in paragraph (e) of LN 6 of 1988 on page 2824, and these entries were read from the page images. Methylamphetamine is also the only substance covered by the Dangerous Drugs (Methylamphetamine) Rules 2025 (Gazette No. 158, 5 November 2025), made 'under section 15, Proclamation (LN 101 of 1987) and Proclamation (LN 6 of 1988)', which came into force on publication and state possession, supply or distribution, and manufacture offences. Paragraph 2 of the 1987 schedule extends Part III to 'Any stereoisomeric form of a substance specified in paragraph 1 not being dextromethorphan or dextrorphan', paragraph 3 to 'Any ester or ether' of such a substance, and paragraph 4 to 'Any salt'. Paragraph 5 reaches 'Any preparations or other product containing a substance' of paragraphs 1 to 4 'not being a preparation specified in Schedule 1'; no Schedule 1 appears in the pages read, so which preparations stand outside the control is not established. LN 6 of 1988 paragraphs (d) and (h) (printed page 2824) refer instead to 'the Schedule to the Proclamation referred to in paragraph (a)', so 'Schedule 1' in LN 101 paragraphs 5 and 9 may mean the paragraph 1 list of that Schedule; no instrument read states that reading. The second list is paragraph 6 on printed page 2823 and paragraph (e) of LN 6 of 1988 on printed page 2824, both of which repeat the name; what the second list adds to a name already in paragraph 1 is not stated in the instruments read. The margin note on printed page 2824 reads LN 61/1988 while the heading on page 2821 and the 2025 Rules cite LN 6 of 1988, and paragraph (g) is absent between (f) and (h) on that page; both were seen on the image. Amphetamine and Dexamphetamine are separate named entries and are not the answer for methylamphetamine. The Poisons List in Schedule B Part I of the Pharmacy and Poisons Act names 'Amphetamines (beta-aminopropylbenzene and beta-amino-isopropylbenzene)'. The verdict does not rely on that entry: it names two compounds in a parenthesis, and whether its plural heading reaches methylamphetamine is not stated, so that reach is open and the verdict rests on the named entries and the 2025 Rules. The named entries and the 2025 Rules govern. Methylamphetamine is also printed in the Fourth Schedule to the Poisons Rules (page 3033), which is a sale restriction and does not change the drug control above.
Consequences if caught: Under the 2025 Rules. Personal possession: rule 4 reads 'A person who is in possession of methylamphetamine without a licence or in contravention of the provisions of the Act or the Pharmacy and Poisons Act (Cap.105), commits an offence', and rule 3 defines possession as 'having any amount of methylamphetamine on someone' including on body, clothing, bag or purse, at an office or work station, in a vehicle, in a building or a home, or at any owned location. There is no quantity threshold and no distinction between a small and a large amount. Supply and distribution: rule 5 makes it an offence to supply or distribute methylamphetamine without a licence or in contravention of the Act or the Pharmacy and Poisons Act; rule 3 defines supply to include 'small or large scale selling' and providing raw material or chemicals for production, and distribution to include transporting or moving it around. Sale is therefore inside rule 5, and the Rules state no separate offence of possession for supply or of trafficking by those names. Manufacture: rule 6 makes it an offence to manufacture or prepare for manufacturing methylamphetamine without a licence or in contravention of the Act or the Pharmacy and Poisons Act, and rule 3 defines manufacture as the mixing or preparing of raw materials or chemicals for its production. Penalty: rule 7 reads 'A person who commits an offence under these Rules are subject to the penalties, proceedings and all relevant provisions of the Act'. The Rules state no penalty of their own, and rule 7 is read here with section 39(1)(a) of the Act (contravening a rule made under it) and section 39(2), the penalty for an offence for which none is otherwise prescribed. Under section 39(2) the fine is 100,000 penalty units, or imprisonment for ten years, or both, on conviction by the court sitting with assessors, and 5,000 penalty units, or imprisonment for six months, or both, on summary conviction, with forfeiture of all articles in respect of which the offence was committed; fine and imprisonment may be cumulative. Section 39(3) requires the consent of the Director of Public Prosecutions for proceedings under section 39(1)(a), and section 39(4) gives attempting, soliciting and inciting the same punishment. The Act does not state the value of a penalty unit and none is converted here. Under the Act. Import and export are two separate offences: section 14 prohibits them except in accordance with sections 22 to 30, section 3 limits entry and exit to an approved port, and a person exporting in contravention is also liable under section 35(2) to forfeit treble the value of the goods or 2,000 penalty units. Section 20 separately makes possession of a Part III drug an offence unless the person proves it was obtained under the authority of the Act, on a prescription of a registered medical practitioner, or from a person having authority to sell it. Cultivation: no cultivation offence applies to methylamphetamine. Use or consumption: the instruments read state no separate offence of use, so possession is the exposure. The Act's drug provisions and the Rules state no death penalty. Not established: the Rules refer to a licence but print no licensing scheme, so how a person lawfully dispensed the drug on a prescription fits within rule 4 is not stated in the Rules.
If prescribed / medical: The medical route is in the Dangerous Drugs Act itself. Section 15(1)(c) lets the Minister make rules regulating the issue by medical practitioners of prescriptions containing a Part III drug and the dispensing of them, and section 15(2) requires the rules to authorise a pharmaceutical chemist or chemist and druggist to retail, dispense or compound such drugs in the ordinary course of business. Section 19 limits withdrawal from the store to a registered medical practitioner, licensed pharmacist, registered dentist, qualified veterinary surgeon, a hospital attendant approved at a plantation hospital, or a person approved for recognised Mission medical work. Section 20 lets a person found with the drug prove that it was obtained in accordance with the prescription of a registered medical practitioner. Section 39(3) bars imprisonment without the option of a fine, and caps the fine at 100 penalty units, for an inadvertent breach of the rules on keeping books or on prescriptions. Rules under section 15 other than the 2025 methylamphetamine rules were not located, so detailed prescription rules for methylamphetamine are not verified beyond the references in rules 4 to 6 of the 2025 Rules to a licence and to the Pharmacy and Poisons Act. The Pharmacy and Poisons Act (Cap. 105, reprint as in force 5 February 2024) also speaks to prescriptions for these drugs in its own text. Section 36(4) reads 'A prescription which does not comply with the provisions of this section shall not be accepted by any pharmacist as authority for the sale or supply of any medicine or drug'. Section 37(2) reads that every prescription 'containing any of the drugs to which any Act as to the sale of dangerous drugs, for the time being in force, relates, shall be retained in the custody of the pharmacist dispensing the same for a period of two years and filed in the pharmacy'. Section 38(c) provides that a pharmacist shall not 'permit any person, other than a registered pharmacist, to dispense or compound any prescription or supply any medicine or drugs containing any of the dangerous drugs to which subsection (2) of section 37 relates'. The Fourth Schedule to the Poisons Rules lists 'Methylamphetamine' with no exception (printed page 3033). Rule 11(1) of the Poisons Rules (printed page 3004) reads 'It shall not be lawful to sell any poison included in the Fourth Schedule to these Rules except on and in accordance with the prescription given by a registered medical practitioner, registered dentist or a qualified veterinary surgeon in the form provided by this rule'. Rule 11(2) applies it to a sale even where the sale is exempted by section 57 of the Act, but not to a sale exempted by section 58 (wholesale dealing, and sales to a practitioner for his profession). Under rule 11(3) a prescription must be in writing, signed with the usual signature and dated, give the prescriber's address, give the name and address of the person treated (or of the person to whom the medicine is delivered, if given by a veterinary surgeon), and indicate the total amount to be supplied and the dose to be taken. Under rule 11(4) it may not be dispensed more than once unless the prescriber states that it may, the dispenser must note the seller's name, address and date on it, and it must be kept on the premises for two years. Section 2 of the Act reads 'poison includes the several substances mentioned in the poisons list in Schedule B', and rule 2(1) of the Poisons Rules (printed pages 3000 and 3001) defines 'poisons list' as 'the Poisons List contained in Schedule B of the Act'. Rule 11 is a sale rule under the pharmacy law and is separate from drug control under the Dangerous Drugs Act. The Poisons Rules were read as printed in the 1996 Revised Edition with margin notes amended to LN 63 of 1988; whether they were amended later or are still in force is not established, and the 2024 reprint of the Act does not print them.
Documentation: Importing methylamphetamine as a Part III drug requires an import authorisation in Form C granted by the Permanent Secretary, Ministry of Health and Medical Services under section 26, and section 28 provides that no dangerous drug shall be imported unless the person to whom it is consigned holds a valid and subsisting import authorisation. Section 29 requires an export authorisation or diversion certificate from a country party to the Convention to accompany the drug, and section 31 sets the transit conditions. Section 3 limits import and export to a port approved by notice; the notice printed at page 2821 of the 1996 edition (LN 41 of 1968, dated 24 September 1968) approves Honiara port and Henderson aerodrome, and later notices were not read. The only quantity exemption in the transit rules is section 31(5), for quantities that bona fide form part of the medical stores of a ship or aircraft. The sections read state no exemption for a traveller's personal supply, so none is established, and the Convention as defined in section 2 names only the 1912, 1925 and 1931 instruments. Under the Pharmacy and Poisons Act section 52(1) forbids importing 'any poison' except under a licence issued by the Board, with a proviso for qualified practitioners, registered pharmacists, veterinary surgeons and dentists importing for bona fide treatment; the proviso does not mention a traveller. The Customs and Excise Act was not read. A Dangerous Drugs (Amendment) Bill 2025 is reported as before Parliament; it was not read, and a Bill is not law.

Dangerous Drugs Act (Cap. 98), reprint as in force 1 October 2009, sections 2, 3, 4 to 8, 11 to 15, 19 to 21, 26 to 31, 35 and 39 · attorneygenerals.gov.sb · Proclamations LN 101 of 1987 and LN 6 of 1988 applying Part III, as printed in the 1996 Revised Edition, Cap. 98 subsidiary legislation, printed pages 2821 to 2824 · solomon-islands.tradeportal.org · Dangerous Drugs (Methylamphetamine) Rules 2025, Gazette No. 158 of 5 November 2025, rules 1 to 7 · solomons.gov.sb · Pharmacy and Poisons Act (Cap. 105), reprint as in force 5 February 2024, sections 36 to 38 and 44 to 62 and Schedule B Poisons List · attorneygenerals.gov.sb · Poisons Rules under the Pharmacy and Poisons Act (Cap. 105), 1996 Revised Edition, printed pages 3000 to 3043, rules 2 and 11 and the Fourth Schedule · solomon-islands.tradeportal.org · Chemical identity source, cited as an identity record and not as law: NLM MeSH term T025862, Methylamphetamine, in concept M0013551 (descriptor D008694, Methamphetamine) · id.nlm.nih.gov · NLM MeSH term T025864, Metamfetamine, in the same concept · id.nlm.nih.gov · Updated October 7, 2026

Methamphetamine in Solomon Islands, full detail →

Methaqualone (Quaaludes)

Legal status: Controlled. Methaqualone is named in the schedule to the proclamation of 21 September 1987 (LN 101 of 1987) that applies Part III of the Dangerous Drugs Act (Cap. 98, reprint as in force 1 October 2009) under section 13(2): paragraph 1, printed page 2822, lists 'Methaqualone'. It is listed again in paragraph 6 on page 2823 and in paragraph (e) of LN 6 of 1988 on page 2824, read from the page images. Paragraph 2 of the 1987 schedule extends Part III to 'Any stereoisomeric form of a substance specified in paragraph 1 not being dextromethorphan or dextrorphan', paragraph 3 to 'Any ester or ether' of such a substance, and paragraph 4 to 'Any salt'. Paragraph 5 reaches 'Any preparations or other product containing a substance' of paragraphs 1 to 4 'not being a preparation specified in Schedule 1'; no Schedule 1 appears in the pages read, so which preparations stand outside the control is not established. LN 6 of 1988 paragraphs (d) and (h) (printed page 2824) refer instead to 'the Schedule to the Proclamation referred to in paragraph (a)', so 'Schedule 1' in LN 101 paragraphs 5 and 9 may mean the paragraph 1 list of that Schedule; no instrument read states that reading. The second list is paragraph 6 on printed page 2823 and paragraph (e) of LN 6 of 1988 on printed page 2824, both of which repeat the name; what the second list adds to a name already in paragraph 1 is not stated in the instruments read. The margin note on printed page 2824 reads LN 61/1988 while the heading on page 2821 and the 2025 Rules cite LN 6 of 1988, and paragraph (g) is absent between (f) and (h) on that page; both were seen on the image. No other instrument read names it as a dangerous drug, and the named entry governs. Methaqualone is a single compound with its own entry and is not reached through any class. It is also printed in the Fourth Schedule to the Poisons Rules (page 3033), which is a sale restriction and does not change the drug control above. It is not in the Poisons List in Schedule B, and the 2025 Rules apply to methylamphetamine only.
Consequences if caught: Methaqualone as a Part III drug through the proclamations. Personal possession: section 20 makes it an offence against the Act when a Part III drug is found in a person's possession or kept in any place other than the appointed store, unless he can prove that it was obtained under the authority of the Act, or in accordance with the prescription of a registered medical practitioner, or from a person having authority to sell it, or was deposited there without his knowledge or consent. The burden of proof is on the accused and section 20 sets no quantity threshold. Possession for supply and trafficking: the Act's text states no separate offence of possession for supply or of trafficking for Part III drugs. Sale and distribution: these are matters for rules the Minister may make under section 15(1)(b), and the only rules located are the 2025 methylamphetamine rules, which apply to methylamphetamine alone, so a sale offence for methaqualone is not verified beyond the general offence in section 39(1)(a) of contravening the Act or a rule under it. Import and export are two separate offences: section 14 prohibits them except in accordance with sections 22 to 30, section 3 limits entry and exit to an approved port, and a person exporting in contravention is also liable under section 35(2) to forfeit treble the value of the goods or 2,000 penalty units, at the option of the Comptroller of Customs and Excise. Manufacture: section 15(1)(a) lets rules prohibit manufacture except on licensed premises, and the Act's text states no manufacture offence itself. Cultivation: the instruments read state no cultivation offence for methaqualone; the plant offences in sections 7 and 8 concern the opium poppy, Indian hemp and coca leaf plants only. Use or consumption: the instruments read state no separate offence of use for Part III drugs, so possession under section 20 is the exposure. Administrative offences: section 39(1)(b) and (c) cover breach of licence conditions and false statements to obtain a licence or authority. Penalty: no penalty is otherwise prescribed, so section 39(2) applies to each offence. On conviction by the court sitting with assessors the fine is 100,000 penalty units, or imprisonment for ten years, or both; on summary conviction the fine is 5,000 penalty units, or imprisonment for six months, or both; and in every case all articles in respect of which the offence was committed are forfeited. Fine and imprisonment may be cumulative ('or to both such fine and imprisonment'). Section 39(4) gives attempting, soliciting and inciting the same punishment, and section 39(3) requires the consent of the Director of Public Prosecutions for proceedings under section 39(1)(a). The Act's drug provisions read state no death penalty. The Act does not state the value of a penalty unit and none is converted here.
If prescribed / medical: The medical route is in the Dangerous Drugs Act itself. Section 15(1)(c) lets the Minister make rules regulating the issue by medical practitioners of prescriptions containing a Part III drug and the dispensing of them, and section 15(2) requires the rules to authorise a pharmaceutical chemist or chemist and druggist to retail, dispense or compound such drugs in the ordinary course of business. Section 19 limits withdrawal from the store to a registered medical practitioner, licensed pharmacist, registered dentist, qualified veterinary surgeon, a hospital attendant approved at a plantation hospital, or a person approved for recognised Mission medical work. Section 20 lets a person found with the drug prove that it was obtained in accordance with the prescription of a registered medical practitioner. Section 39(3) bars imprisonment without the option of a fine, and caps the fine at 100 penalty units, for an inadvertent breach of the rules on keeping books or on prescriptions. Rules under section 15 other than the 2025 methylamphetamine rules were not located, so detailed prescription rules for methaqualone are not verified. The Pharmacy and Poisons Act (Cap. 105, reprint as in force 5 February 2024) also speaks to prescriptions for these drugs in its own text. Section 36(4) reads 'A prescription which does not comply with the provisions of this section shall not be accepted by any pharmacist as authority for the sale or supply of any medicine or drug'. Section 37(2) reads that every prescription 'containing any of the drugs to which any Act as to the sale of dangerous drugs, for the time being in force, relates, shall be retained in the custody of the pharmacist dispensing the same for a period of two years and filed in the pharmacy'. Section 38(c) provides that a pharmacist shall not 'permit any person, other than a registered pharmacist, to dispense or compound any prescription or supply any medicine or drugs containing any of the dangerous drugs to which subsection (2) of section 37 relates'. The Fourth Schedule to the Poisons Rules lists 'Methaqualone' with no exception (printed page 3033), immediately after 'Methandriol' and before 'Metharbitone'. Rule 11(1) of the Poisons Rules (printed page 3004) reads 'It shall not be lawful to sell any poison included in the Fourth Schedule to these Rules except on and in accordance with the prescription given by a registered medical practitioner, registered dentist or a qualified veterinary surgeon in the form provided by this rule'. Rule 11(2) applies it to a sale even where the sale is exempted by section 57 of the Act, but not to a sale exempted by section 58 (wholesale dealing, and sales to a practitioner for his profession). Under rule 11(3) a prescription must be in writing, signed with the usual signature and dated, give the prescriber's address, give the name and address of the person treated (or of the person to whom the medicine is delivered, if given by a veterinary surgeon), and indicate the total amount to be supplied and the dose to be taken. Under rule 11(4) it may not be dispensed more than once unless the prescriber states that it may, the dispenser must note the seller's name, address and date on it, and it must be kept on the premises for two years. Section 2 of the Act reads 'poison includes the several substances mentioned in the poisons list in Schedule B', and rule 2(1) of the Poisons Rules (printed pages 3000 and 3001) defines 'poisons list' as 'the Poisons List contained in Schedule B of the Act'. Rule 11 is a sale rule under the pharmacy law and is separate from drug control under the Dangerous Drugs Act. The Poisons Rules were read as printed in the 1996 Revised Edition with margin notes amended to LN 63 of 1988; whether they were amended later or are still in force is not established, and the 2024 reprint of the Act does not print them.
Documentation: Importing methaqualone as a Part III drug requires an import authorisation in Form C granted by the Permanent Secretary, Ministry of Health and Medical Services under section 26, and section 28 provides that no dangerous drug shall be imported unless the person to whom it is consigned holds a valid and subsisting import authorisation. Section 29 requires an export authorisation or diversion certificate from a country party to the Convention to accompany the drug, and section 31 sets the transit conditions. Section 3 limits import and export to a port approved by notice; the notice printed at page 2821 of the 1996 edition (LN 41 of 1968, dated 24 September 1968) approves Honiara port and Henderson aerodrome, and later notices were not read. The only quantity exemption in the transit rules is section 31(5), for quantities that bona fide form part of the medical stores of a ship or aircraft. The sections read state no exemption for a traveller's personal supply, so none is established, and the Convention as defined in section 2 names only the 1912, 1925 and 1931 instruments. Under the Pharmacy and Poisons Act section 52(1) forbids importing 'any poison' except under a licence issued by the Board, with a proviso for qualified practitioners, registered pharmacists, veterinary surgeons and dentists importing for bona fide treatment; the proviso does not mention a traveller. The Customs and Excise Act was not read. A Dangerous Drugs (Amendment) Bill 2025 is reported as before Parliament; it was not read, and a Bill is not law.

Methaqualone (Quaaludes) in Solomon Islands, full detail →

Methylphenidate

Legal status: Controlled. Methylphenidate is named in the schedule to the proclamation of 21 September 1987 (LN 101 of 1987) that applies Part III of the Dangerous Drugs Act (Cap. 98, reprint as in force 1 October 2009) under section 13(2): paragraph 1, printed page 2822, lists 'Methylphenidate'. It is listed again in paragraph 6 on page 2823 and in paragraph (e) of LN 6 of 1988 on page 2824, read from the page images. Paragraph 2 of the 1987 schedule extends Part III to 'Any stereoisomeric form of a substance specified in paragraph 1 not being dextromethorphan or dextrorphan', paragraph 3 to 'Any ester or ether' of such a substance, and paragraph 4 to 'Any salt'. Paragraph 5 reaches 'Any preparations or other product containing a substance' of paragraphs 1 to 4 'not being a preparation specified in Schedule 1'; no Schedule 1 appears in the pages read, so which preparations stand outside the control is not established. LN 6 of 1988 paragraphs (d) and (h) (printed page 2824) refer instead to 'the Schedule to the Proclamation referred to in paragraph (a)', so 'Schedule 1' in LN 101 paragraphs 5 and 9 may mean the paragraph 1 list of that Schedule; no instrument read states that reading. The second list is paragraph 6 on printed page 2823 and paragraph (e) of LN 6 of 1988 on printed page 2824, both of which repeat the name; what the second list adds to a name already in paragraph 1 is not stated in the instruments read. The margin note on printed page 2824 reads LN 61/1988 while the heading on page 2821 and the 2025 Rules cite LN 6 of 1988, and paragraph (g) is absent between (f) and (h) on that page; both were seen on the image. The named entry governs, and the control does not turn on whether the use is medical: the medical route is a separate set of provisions (see the prescription field). It is also printed in the Fourth Schedule to the Poisons Rules (page 3033) with no exception, which is a sale restriction and does not change the drug control above.
Consequences if caught: Methylphenidate as a Part III drug through the proclamations. Personal possession: section 20 makes it an offence against the Act when a Part III drug is found in a person's possession or kept in any place other than the appointed store, unless he can prove that it was obtained under the authority of the Act, or in accordance with the prescription of a registered medical practitioner, or from a person having authority to sell it, or was deposited there without his knowledge or consent. The burden of proof is on the accused and section 20 sets no quantity threshold. Possession for supply and trafficking: the Act's text states no separate offence of possession for supply or of trafficking for Part III drugs. Sale and distribution: these are matters for rules the Minister may make under section 15(1)(b), and the only rules located are the 2025 methylamphetamine rules, which apply to methylamphetamine alone, so a sale offence for methylphenidate is not verified beyond the general offence in section 39(1)(a) of contravening the Act or a rule under it. Import and export are two separate offences: section 14 prohibits them except in accordance with sections 22 to 30, section 3 limits entry and exit to an approved port, and a person exporting in contravention is also liable under section 35(2) to forfeit treble the value of the goods or 2,000 penalty units, at the option of the Comptroller of Customs and Excise. Manufacture: section 15(1)(a) lets rules prohibit manufacture except on licensed premises, and the Act's text states no manufacture offence itself. Cultivation: the instruments read state no cultivation offence for methylphenidate; the plant offences in sections 7 and 8 concern the opium poppy, Indian hemp and coca leaf plants only. Use or consumption: the instruments read state no separate offence of use for Part III drugs, so possession under section 20 is the exposure. Administrative offences: section 39(1)(b) and (c) cover breach of licence conditions and false statements to obtain a licence or authority. Penalty: no penalty is otherwise prescribed, so section 39(2) applies to each offence. On conviction by the court sitting with assessors the fine is 100,000 penalty units, or imprisonment for ten years, or both; on summary conviction the fine is 5,000 penalty units, or imprisonment for six months, or both; and in every case all articles in respect of which the offence was committed are forfeited. Fine and imprisonment may be cumulative ('or to both such fine and imprisonment'). Section 39(4) gives attempting, soliciting and inciting the same punishment, and section 39(3) requires the consent of the Director of Public Prosecutions for proceedings under section 39(1)(a). The Act's drug provisions read state no death penalty. The Act does not state the value of a penalty unit and none is converted here.
If prescribed / medical: The medical route is in the Dangerous Drugs Act itself. Section 15(1)(c) lets the Minister make rules regulating the issue by medical practitioners of prescriptions containing a Part III drug and the dispensing of them, and section 15(2) requires the rules to authorise a pharmaceutical chemist or chemist and druggist to retail, dispense or compound such drugs in the ordinary course of business. Section 19 limits withdrawal from the store to a registered medical practitioner, licensed pharmacist, registered dentist, qualified veterinary surgeon, a hospital attendant approved at a plantation hospital, or a person approved for recognised Mission medical work. Section 20 lets a person found with the drug prove that it was obtained in accordance with the prescription of a registered medical practitioner. Section 39(3) bars imprisonment without the option of a fine, and caps the fine at 100 penalty units, for an inadvertent breach of the rules on keeping books or on prescriptions. Rules under section 15 other than the 2025 methylamphetamine rules were not located, so detailed prescription rules for methylphenidate are not verified. The Pharmacy and Poisons Act (Cap. 105, reprint as in force 5 February 2024) also speaks to prescriptions for these drugs in its own text. Section 36(4) reads 'A prescription which does not comply with the provisions of this section shall not be accepted by any pharmacist as authority for the sale or supply of any medicine or drug'. Section 37(2) reads that every prescription 'containing any of the drugs to which any Act as to the sale of dangerous drugs, for the time being in force, relates, shall be retained in the custody of the pharmacist dispensing the same for a period of two years and filed in the pharmacy'. Section 38(c) provides that a pharmacist shall not 'permit any person, other than a registered pharmacist, to dispense or compound any prescription or supply any medicine or drugs containing any of the dangerous drugs to which subsection (2) of section 37 relates'. The Fourth Schedule to the Poisons Rules lists 'Methylphenidate' with no exception (printed page 3033), so no strength or preparation is shown to be sold without a prescription. Rule 11(1) of the Poisons Rules (printed page 3004) reads 'It shall not be lawful to sell any poison included in the Fourth Schedule to these Rules except on and in accordance with the prescription given by a registered medical practitioner, registered dentist or a qualified veterinary surgeon in the form provided by this rule'. Rule 11(2) applies it to a sale even where the sale is exempted by section 57 of the Act, but not to a sale exempted by section 58 (wholesale dealing, and sales to a practitioner for his profession). Under rule 11(3) a prescription must be in writing, signed with the usual signature and dated, give the prescriber's address, give the name and address of the person treated (or of the person to whom the medicine is delivered, if given by a veterinary surgeon), and indicate the total amount to be supplied and the dose to be taken. Under rule 11(4) it may not be dispensed more than once unless the prescriber states that it may, the dispenser must note the seller's name, address and date on it, and it must be kept on the premises for two years. Section 2 of the Act reads 'poison includes the several substances mentioned in the poisons list in Schedule B', and rule 2(1) of the Poisons Rules (printed pages 3000 and 3001) defines 'poisons list' as 'the Poisons List contained in Schedule B of the Act'. Rule 11 is a sale rule under the pharmacy law and is separate from drug control under the Dangerous Drugs Act. The Poisons Rules were read as printed in the 1996 Revised Edition with margin notes amended to LN 63 of 1988; whether they were amended later or are still in force is not established, and the 2024 reprint of the Act does not print them.
Documentation: Importing methylphenidate as a Part III drug requires an import authorisation in Form C granted by the Permanent Secretary, Ministry of Health and Medical Services under section 26, and section 28 provides that no dangerous drug shall be imported unless the person to whom it is consigned holds a valid and subsisting import authorisation. Section 29 requires an export authorisation or diversion certificate from a country party to the Convention to accompany the drug, and section 31 sets the transit conditions. Section 3 limits import and export to a port approved by notice; the notice printed at page 2821 of the 1996 edition (LN 41 of 1968, dated 24 September 1968) approves Honiara port and Henderson aerodrome, and later notices were not read. The only quantity exemption in the transit rules is section 31(5), for quantities that bona fide form part of the medical stores of a ship or aircraft. The sections read state no exemption for a traveller's personal supply, so none is established, and the Convention as defined in section 2 names only the 1912, 1925 and 1931 instruments. Under the Pharmacy and Poisons Act section 52(1) forbids importing 'any poison' except under a licence issued by the Board, with a proviso for qualified practitioners, registered pharmacists, veterinary surgeons and dentists importing for bona fide treatment; the proviso does not mention a traveller. The Customs and Excise Act was not read. A Dangerous Drugs (Amendment) Bill 2025 is reported as before Parliament; it was not read, and a Bill is not law.

Methylphenidate in Solomon Islands, full detail →

Morphine

Legal status: Controlled. Morphine is named by the Dangerous Drugs Act (Cap. 98, reprint as in force 1 October 2009) itself, without any proclamation. Section 13(1)(c) applies Part III to 'morphine and its salts and diacetylmorphine (commonly known as diamorphine or heroin) and the other esters of morphine and their respective salts', and section 2 defines morphine as 'the principal alkaloid of opium having the formula C17H19O3N'. Section 13(1)(e) also reaches 'any dilution or solution of morphine or cocaine or their salts in an inert substance... containing any proportion of morphine or cocaine', and 'any preparation, admixture, extract or other substance' containing not less than one fifth per centum of morphine, calculated as anhydrous morphine. The proclamation of 21 September 1987 (LN 101 of 1987), paragraph 1, printed page 2822, also lists 'Morphine' and 'Morphine methobromide, morphine N-oxide and other pentavalent nitrogen morphine derivatives', read from the page image. Morphine is also in the Poisons List, Schedule B Part I of the Pharmacy and Poisons Act (as in force 5 February 2024), in the first schedule to the Poisons Rules with 'except substances containing less than 0.2 per cent of morphine calculated as anhydrous morphine' (printed page 3013), and in the Fourth Schedule (page 3034), which are sale restrictions and do not change the drug control above. The named entries govern.
Consequences if caught: Morphine as a Part III drug through section 13(1) of the Act. Personal possession: section 20 makes it an offence against the Act when a Part III drug is found in a person's possession or kept in any place other than the appointed store, unless he can prove that it was obtained under the authority of the Act, or in accordance with the prescription of a registered medical practitioner, or from a person having authority to sell it, or was deposited there without his knowledge or consent. The burden of proof is on the accused and section 20 sets no quantity threshold. Possession for supply and trafficking: the Act's text states no separate offence of possession for supply or of trafficking for Part III drugs. Sale and distribution: these are matters for rules the Minister may make under section 15(1)(b), and the only rules located are the 2025 methylamphetamine rules, which apply to methylamphetamine alone, so a sale offence for morphine is not verified beyond the general offence in section 39(1)(a) of contravening the Act or a rule under it. Section 8(b), which makes it an offence to be found in possession of or to sell a substance, is in Part I and applies to raw opium, coca leaf and Indian hemp and not to morphine. Import and export are two separate offences: section 14 prohibits them except in accordance with sections 22 to 30, section 3 limits entry and exit to an approved port, and a person exporting in contravention is also liable under section 35(2) to forfeit treble the value of the goods or 2,000 penalty units, at the option of the Comptroller of Customs and Excise. Manufacture: section 15(1)(a) lets rules prohibit manufacture except on licensed premises, and the Act's text states no manufacture offence itself. Cultivation: the instruments read state no cultivation offence for morphine; the plant offences in sections 7 and 8 concern the opium poppy, Indian hemp and coca leaf plants only. Use or consumption: the instruments read state no separate offence of use for Part III drugs, so possession under section 20 is the exposure. Administrative offences: section 39(1)(b) and (c) cover breach of licence conditions and false statements to obtain a licence or authority. Penalty: no penalty is otherwise prescribed, so section 39(2) applies to each offence. On conviction by the court sitting with assessors the fine is 100,000 penalty units, or imprisonment for ten years, or both; on summary conviction the fine is 5,000 penalty units, or imprisonment for six months, or both; and in every case all articles in respect of which the offence was committed are forfeited. Fine and imprisonment may be cumulative ('or to both such fine and imprisonment'). Section 39(4) gives attempting, soliciting and inciting the same punishment, and section 39(3) requires the consent of the Director of Public Prosecutions for proceedings under section 39(1)(a). The Act's drug provisions read state no death penalty. The Act does not state the value of a penalty unit and none is converted here. Percentage test: the section 13(1)(e) threshold of one fifth per centum for other preparations means a weak preparation can fall outside Part III, but a dilution or solution in an inert substance is caught at any proportion.
If prescribed / medical: The medical route is in the Dangerous Drugs Act itself. Section 15(1)(c) lets the Minister make rules regulating the issue by medical practitioners of prescriptions containing a Part III drug and the dispensing of them, and section 15(2) requires the rules to authorise a pharmaceutical chemist or chemist and druggist to retail, dispense or compound such drugs in the ordinary course of business. Section 19 limits withdrawal from the store to a registered medical practitioner, licensed pharmacist, registered dentist, qualified veterinary surgeon, a hospital attendant approved at a plantation hospital, or a person approved for recognised Mission medical work. Section 20 lets a person found with the drug prove that it was obtained in accordance with the prescription of a registered medical practitioner. Section 39(3) bars imprisonment without the option of a fine, and caps the fine at 100 penalty units, for an inadvertent breach of the rules on keeping books or on prescriptions. Rules under section 15 other than the 2025 methylamphetamine rules were not located, so detailed prescription rules for morphine are not verified. The Pharmacy and Poisons Act (Cap. 105, reprint as in force 5 February 2024) also speaks to prescriptions for these drugs in its own text. Section 36(4) reads 'A prescription which does not comply with the provisions of this section shall not be accepted by any pharmacist as authority for the sale or supply of any medicine or drug'. Section 37(2) reads that every prescription 'containing any of the drugs to which any Act as to the sale of dangerous drugs, for the time being in force, relates, shall be retained in the custody of the pharmacist dispensing the same for a period of two years and filed in the pharmacy'. Section 38(c) provides that a pharmacist shall not 'permit any person, other than a registered pharmacist, to dispense or compound any prescription or supply any medicine or drugs containing any of the dangerous drugs to which subsection (2) of section 37 relates'. The Fourth Schedule to the Poisons Rules lists 'Morphine' with no exception (printed page 3034), between 'Morpheridine' and 'Morazone Hydrochloride'. Rule 11(1) of the Poisons Rules (printed page 3004) reads 'It shall not be lawful to sell any poison included in the Fourth Schedule to these Rules except on and in accordance with the prescription given by a registered medical practitioner, registered dentist or a qualified veterinary surgeon in the form provided by this rule'. Rule 11(2) applies it to a sale even where the sale is exempted by section 57 of the Act, but not to a sale exempted by section 58 (wholesale dealing, and sales to a practitioner for his profession). Under rule 11(3) a prescription must be in writing, signed with the usual signature and dated, give the prescriber's address, give the name and address of the person treated (or of the person to whom the medicine is delivered, if given by a veterinary surgeon), and indicate the total amount to be supplied and the dose to be taken. Under rule 11(4) it may not be dispensed more than once unless the prescriber states that it may, the dispenser must note the seller's name, address and date on it, and it must be kept on the premises for two years. Section 2 of the Act reads 'poison includes the several substances mentioned in the poisons list in Schedule B', and rule 2(1) of the Poisons Rules (printed pages 3000 and 3001) defines 'poisons list' as 'the Poisons List contained in Schedule B of the Act'. Rule 11 is a sale rule under the pharmacy law and is separate from drug control under the Dangerous Drugs Act. The Poisons Rules were read as printed in the 1996 Revised Edition with margin notes amended to LN 63 of 1988; whether they were amended later or are still in force is not established, and the 2024 reprint of the Act does not print them.
Documentation: Importing morphine as a Part III drug requires an import authorisation in Form C granted by the Permanent Secretary, Ministry of Health and Medical Services under section 26, and section 28 provides that no dangerous drug shall be imported unless the person to whom it is consigned holds a valid and subsisting import authorisation. Section 29 requires an export authorisation or diversion certificate from a country party to the Convention to accompany the drug, and section 31 sets the transit conditions. Section 3 limits import and export to a port approved by notice; the notice printed at page 2821 of the 1996 edition (LN 41 of 1968, dated 24 September 1968) approves Honiara port and Henderson aerodrome, and later notices were not read. The only quantity exemption in the transit rules is section 31(5), for quantities that bona fide form part of the medical stores of a ship or aircraft. The sections read state no exemption for a traveller's personal supply, so none is established, and the Convention as defined in section 2 names only the 1912, 1925 and 1931 instruments. Under the Pharmacy and Poisons Act section 52(1) forbids importing 'any poison' except under a licence issued by the Board, with a proviso for qualified practitioners, registered pharmacists, veterinary surgeons and dentists importing for bona fide treatment; the proviso does not mention a traveller. The Customs and Excise Act was not read. A Dangerous Drugs (Amendment) Bill 2025 is reported as before Parliament; it was not read, and a Bill is not law.

Morphine in Solomon Islands, full detail →

Nicotine

Legal status: Restricted as a poison, with sale by an authorised seller of poisons or the holder of a Poisons Licence, on registered premises. Nicotine is a listed Part II poison, and the nicotine in tobacco is carved out. The Pharmacy and Poisons Act (Cap. 105), reprint as in force 5 February 2024, Schedule B (the Poisons List) Part II, names 'Nicotine; its salts.' Part II poisons may be sold only by an authorised seller of poisons on registered premises, or by the holder of a Poisons Licence on registered premises (section 56(1)(b)). The Poisons Rules (1996 Revised Edition, margin notes amended to LN 63 of 1988) list 'Nicotine.' in the First Schedule (printed page 3014), the schedule of substances in the Poisons List 'to which special restrictions apply'. Rule 5 (printed page 3002) extends section 56(2) of the Act 'to all substances included in the First Schedule to these Rules whether or not the poison sold is a poison included in Part I of the Poisons List', and rule 13(1) (printed pages 3005 and 3006) provides that no licensed seller of poisons 'shall be entitled by virtue of being a licensed seller of Part II poisons to sell' any poison other than ammonia, hydrochloric acid, methylated spirits, nitric acid, potassium quadroxalate and sulphuric acid 'except in a closed container as closed by the manufacturer or other person from whom the poison was obtained', or 'any substance included in the First Schedule to these Rules unless the sale is effected by himself or by a responsible deputy'. Group II of the Third Schedule (printed page 3017) lists the poison 'Nicotine.' against the article 'Tobacco.', and rule 10(b) provides that nothing in Part VI of the Act or the Rules applies to the articles named opposite a poison in Group II, so the poison rules do not apply to tobacco. Tobacco products are regulated by the Tobacco Control Act 2010 (as in force 5 February 2024), which was read; see the tobacco answer for that regime. Nicotine is not named in either proclamation list read and is not in the Fourth Schedule (neighbouring entries 'Nicotinaldehyde Thiosemicarbazone', 'Nicocodinone' and 'Nicomorphine' on page 3034 are different substances), so it is a sale restriction and not drug control and not a prescription only medicine on the pages read. The Tobacco Control Act defines 'tobacco' as 'any preparation of dried leaves of the nicotiana tabacum plant of the nightshade family' and 'tobacco product' as any product from tobacco; whether it reaches nicotine that is isolated from the leaf or made, for example in liquids or gum, is not stated, and no instrument read mentions electronic cigarettes or nicotine replacement products. The Poisons Rules were read as printed in the 1996 Revised Edition with margin notes amended to LN 63 of 1988; whether they were amended later or are still in force is not established, and the 2024 reprint of the Act does not print them. The list that carries this entry can move and the text read may be out of date: under section 52(3) and (4) of the Pharmacy and Poisons Act the Minister may by order add an article to the Poisons List, effective three months after Gazette publication, and the reprint read is as in force at 5 February 2024, incorporating amendments only up to the Legislation Amendment, Repeal and Validation Act 2023 (No. 17 of 2023); this text does not rule out a later order or amendment.
Consequences if caught: Possession and use: the instruments read state no offence of possession or use of nicotine as such. Sale of nicotine or its salts: a Part II poison may be sold only as section 56(1)(b) allows, by an authorised seller or a Poisons Licence holder on premises registered under section 55, in a container labelled with the name of the poison, the word 'poison' and the seller's name and address (section 56(1)(c)). Section 52(2) makes it unlawful to sell or deal in a Poisons List article except in the manner the Act prescribes. Penalty: section 52(5) gives a penalty of 5,000 penalty units, and for a continuing offence a further 300 penalty units a day after conviction, for acting in contravention of section 52. For a breach of section 56 with no specific penalty stated, section 62(1) gives not more than 3,000 penalty units and a further 600 a day. Which figure governs a particular sale is not settled by the pages read. The Act does not state the value of a penalty unit and none is converted here. Import: section 52(1) forbids importing any poison except under a Board licence, with a proviso for qualified practitioners, pharmacists, veterinary surgeons and dentists importing for bona fide treatment; the Tobacco Control Act separately requires a licence to import a tobacco product (section 15). Possession for supply, trafficking, export, manufacture and cultivation of nicotine itself: the instruments read state no separate offence. The Dangerous Drugs Act penalty in section 39(2) is not shown to apply, and the drug provisions read state no death penalty. For tobacco products the offences and penalties are in the Tobacco Control Act (see the tobacco answer).
If prescribed / medical: No prescription route is stated for nicotine. It is not in the Fourth Schedule to the Poisons Rules, so rule 11 does not apply to it by name, and the pages read do not say that nicotine sold as a medicine needs a prescription. Section 57 exempts a medicine supplied by a qualified practitioner or dispensed by a registered pharmacist from the poison sale rules if the labelling and prescription book requirements are met. Whether a nicotine medicine sold by a pharmacist is a 'medicine' under section 57 is not stated. The Poisons Rules were read as printed in the 1996 Revised Edition with margin notes amended to LN 63 of 1988; whether they were amended later or are still in force is not established, and the 2024 reprint of the Act does not print them.
Documentation: No traveller or personal import permit rule for nicotine was found. Section 52(1) of the Pharmacy and Poisons Act forbids importing any poison except under a licence issued by the Board, with a proviso for bona fide treatment that covers qualified practitioners, pharmacists, veterinary surgeons and dentists and does not mention a traveller. Tobacco carried by a traveller is a separate question under section 15(1) of the Tobacco Control Act, which says 'No person shall manufacture, sell, distribute, import or export... any tobacco product except with a licence'; the Act states no personal allowance, and the Customs and Excise Act was not read. The position for a traveller carrying nicotine liquids or gum is not established.

Pharmacy and Poisons Act (Cap. 105), reprint as in force 5 February 2024, sections 44 to 62 and Schedule B Poisons List · attorneygenerals.gov.sb · Poisons Rules under the Pharmacy and Poisons Act (Cap. 105), 1996 Revised Edition, printed pages 3000 to 3043, rules 5, 10, 11 and 13 and the First, Third (Group II) and Fourth Schedules · solomon-islands.tradeportal.org · Tobacco Control Act 2010 (No. 2 of 2010), reprint as in force 5 February 2024, sections 2 and 15 · attorneygenerals.gov.sb · Updated October 7, 2026

Nicotine in Solomon Islands, full detail →

Opium

Legal status: Controlled. Opium is controlled under all three Parts of the Dangerous Drugs Act (Cap. 98, reprint as in force 1 October 2009), and the form matters. Raw opium: section 4(1) applies Part I to 'raw opium, coca leaf and Indian hemp and resins obtained from Indian hemp and preparations of which such resins form the base', and section 2 defines raw opium as 'the spontaneously coagulated juice obtained from the capsules of the Papaver somniferum'. Prepared opium: Part II (sections 11 and 12) applies to 'the product of raw opium obtained by a series of special operations', including dross and residues remaining after opium has been smoked. Medicinal opium: section 13(1)(a) applies Part III to 'medicinal opium', defined in section 2 as raw opium adapted for medicinal use in accordance with the British Pharmacopoeia. The proclamation of 21 September 1987 (LN 101 of 1987), paragraph 1, printed page 2822, also lists 'Medicinal opium' and 'Opium tincture', read from the page image. The poppy plant and its seed are dealt with in Part I (sections 5, 7 and 8). Opium is also in the Poisons List, Schedule B Part I of the Pharmacy and Poisons Act, in the first schedule to the Poisons Rules with 'except substances containing less than 0.2 per cent of morphine calculated as anhydrous morphine' (printed page 3015), and 'Opium Tincture' and 'Poppy Capsule' are printed in the Fourth Schedule (pages 3035 and 3037), which are sale restrictions and do not change the drug control above. The named entries govern.
Consequences if caught: Raw opium (Part I). Import and export: section 4(2) reads 'No person shall import or export any of the substances to which this Part of this Act applies', section 5 bars import or export of any seed of the opium poppy 'or any portion of the aforesaid plants', and section 6 forfeits unlawfully imported or exported substances. Cultivation: section 7 reads 'No person shall cultivate in Solomon Islands the opium poppy', and section 8(a) makes every person 'growing opium poppy... whether for private use or otherwise' guilty of an offence against the Act. Personal possession and sale: section 8(b) makes every person 'found in possession of or selling, or who shall have given or sold, to any person any substance to which this Part of this Act applies' guilty of an offence, with no quantity threshold and no medical exception in Part I. Giving is covered as well as selling. Powers: section 9 lets a police officer enter on a warrant and arrest without a warrant a person carrying or conveying raw opium, and section 10 allows seizure and destruction of poppy found on a plantation. Prepared opium (Part II). Section 11 prohibits import or export of prepared opium and of pipes or utensils for smoking it, and section 12(1) makes it an offence to manufacture, sell or deal in it, to possess it, to permit premises to be used for preparing or smoking it, to manage such premises, to possess pipes or utensils, or for a person who 'smokes or otherwise uses prepared opium, or frequents any place used for the purpose of opium smoking'. Use is therefore an offence for prepared opium. Medicinal opium and opium tincture (Part III). Section 20 makes possession an offence unless the person proves it was obtained under the authority of the Act, on a prescription of a registered medical practitioner, or from a person having authority to sell it; sections 14 and 22 to 30 control import and export; and the sale and manufacture rules the Minister may make under section 15(1) were not located. Penalty: for each of these the Act says guilty of 'an offence against this Act' and prescribes no other penalty, so section 39(2) applies. On conviction by the court sitting with assessors the fine is 100,000 penalty units, or imprisonment for ten years, or both; on summary conviction the fine is 5,000 penalty units, or imprisonment for six months, or both; and all articles are forfeited. Fine and imprisonment may be cumulative. Section 39(4) gives attempting, soliciting and inciting the same punishment, and section 39(3) requires the consent of the Director of Public Prosecutions for proceedings under section 39(1)(a). A person exporting in contravention is also liable under section 35(2) to forfeit treble the value of the goods or 2,000 penalty units. The Act's drug provisions read state no death penalty. The Act does not state the value of a penalty unit and none is converted here.
If prescribed / medical: Only medicinal opium and opium tincture (Part III) have a medical route; raw opium and prepared opium have none in the Act, and Part I has no prescription exception. For Part III the medical route is in the Dangerous Drugs Act: section 15(1)(c) lets the Minister make rules regulating prescriptions containing a Part III drug and their dispensing, section 15(2) requires the rules to authorise a pharmaceutical chemist or chemist and druggist to retail, dispense or compound such drugs, section 19 limits withdrawal from the store to listed medical and approved persons, and section 20 lets a person prove the drug was obtained on a prescription. Rules under section 15 other than the 2025 methylamphetamine rules were not located, so detailed prescription rules are not verified. The Pharmacy and Poisons Act (Cap. 105, reprint as in force 5 February 2024) also speaks to prescriptions for these drugs in its own text. Section 36(4) reads 'A prescription which does not comply with the provisions of this section shall not be accepted by any pharmacist as authority for the sale or supply of any medicine or drug'. Section 37(2) reads that every prescription 'containing any of the drugs to which any Act as to the sale of dangerous drugs, for the time being in force, relates, shall be retained in the custody of the pharmacist dispensing the same for a period of two years and filed in the pharmacy'. Section 38(c) provides that a pharmacist shall not 'permit any person, other than a registered pharmacist, to dispense or compound any prescription or supply any medicine or drugs containing any of the dangerous drugs to which subsection (2) of section 37 relates'. The Poisons Rules add a second route. The Fourth Schedule lists 'Opium Tincture' with no exception (printed page 3035) and 'Poppy Capsule' (printed page 3037); 'Opium' itself and 'Medicinal Opium' were not found as Fourth Schedule entries, so rule 11 applies by name to the tincture and the capsule and not to those two. Rule 11(1) of the Poisons Rules (printed page 3004) reads 'It shall not be lawful to sell any poison included in the Fourth Schedule to these Rules except on and in accordance with the prescription given by a registered medical practitioner, registered dentist or a qualified veterinary surgeon in the form provided by this rule'. Rule 11(2) applies it to a sale even where the sale is exempted by section 57 of the Act, but not to a sale exempted by section 58 (wholesale dealing, and sales to a practitioner for his profession). Under rule 11(3) a prescription must be in writing, signed with the usual signature and dated, give the prescriber's address, give the name and address of the person treated (or of the person to whom the medicine is delivered, if given by a veterinary surgeon), and indicate the total amount to be supplied and the dose to be taken. Under rule 11(4) it may not be dispensed more than once unless the prescriber states that it may, the dispenser must note the seller's name, address and date on it, and it must be kept on the premises for two years. Section 2 of the Act reads 'poison includes the several substances mentioned in the poisons list in Schedule B', and rule 2(1) of the Poisons Rules (printed pages 3000 and 3001) defines 'poisons list' as 'the Poisons List contained in Schedule B of the Act'. Rule 11 is a sale rule under the pharmacy law and is separate from drug control under the Dangerous Drugs Act. The Poisons Rules were read as printed in the 1996 Revised Edition with margin notes amended to LN 63 of 1988; whether they were amended later or are still in force is not established, and the 2024 reprint of the Act does not print them.
Documentation: Importing opium in any form is controlled by the Dangerous Drugs Act. Raw opium and the poppy plant and seed: section 4(2) and section 5 prohibit import and export, and Part I contains no authorisation scheme and no exception for medical use or for a traveller. Prepared opium: section 11 prohibits import and export outright. Medicinal opium and opium tincture: import needs an import authorisation in Form C under section 26, section 28 forbids import without one, section 29 requires an export authorisation or diversion certificate from a country party to the Convention, and section 31 sets transit conditions, with the only quantity exemption in section 31(5) for the medical stores of a ship or aircraft. Section 3 limits entry to an approved port; the notice printed at page 2821 of the 1996 edition (LN 41 of 1968) approves Honiara port and Henderson aerodrome, and later notices were not read. Under the Pharmacy and Poisons Act section 52(1) forbids importing 'any poison' except under a Board licence, with a proviso for qualified practitioners, pharmacists, veterinary surgeons and dentists importing for bona fide treatment; the proviso does not mention a traveller. The Customs and Excise Act was not read. A Dangerous Drugs (Amendment) Bill 2025 is reported as before Parliament; it was not read, and a Bill is not law.

Opium in Solomon Islands, full detail →

Oxycodone

Legal status: Controlled. Oxycodone is named in the schedule to the proclamation of 21 September 1987 (LN 101 of 1987) that applies Part III of the Dangerous Drugs Act (Cap. 98, reprint as in force 1 October 2009) under section 13(2): paragraph 1, printed page 2822, lists 'Oxycodone', read from the page image. Paragraph 2 of the 1987 schedule extends Part III to 'Any stereoisomeric form of a substance specified in paragraph 1 not being dextromethorphan or dextrorphan', paragraph 3 to 'Any ester or ether' of such a substance, and paragraph 4 to 'Any salt'. Paragraph 5 reaches 'Any preparations or other product containing a substance' of paragraphs 1 to 4 'not being a preparation specified in Schedule 1'; no Schedule 1 appears in the pages read, so which preparations stand outside the control is not established. LN 6 of 1988 paragraphs (d) and (h) (printed page 2824) refer instead to 'the Schedule to the Proclamation referred to in paragraph (a)', so 'Schedule 1' in LN 101 paragraphs 5 and 9 may mean the paragraph 1 list of that Schedule; no instrument read states that reading. Separate named entries beside it ('Oxymorphone', 'Hydrocodone', 'Hydromorphone') are different compounds and are not the answer for oxycodone. The Act itself, in section 13(1)(g), names 'dihydrohydroxycodeinone' and the Poisons List names 'Dihydrohydroxycodeinone; its esters'. No reliance is placed on either, because the instruments do not say that oxycodone is that compound, and the proclamation names oxycodone directly. The named entry governs. Oxycodone is also printed in the Fourth Schedule to the Poisons Rules (page 3035) with no exception, which is a sale restriction and does not change the drug control above. It is not in the 2025 Rules, which cover methylamphetamine only. Section 21(1) of the Act bars trade in products obtained from the phenanthrene alkaloids of opium that were not in medical or scientific use on 13 July 1931, unless the Minister proclaims otherwise; the instruments read do not say whether oxycodone is such a product, so the named proclamation entry is the basis and section 21(1) is not applied.
Consequences if caught: Oxycodone as a Part III drug through the proclamations. Personal possession: section 20 makes it an offence against the Act when a Part III drug is found in a person's possession or kept in any place other than the appointed store, unless he can prove that it was obtained under the authority of the Act, or in accordance with the prescription of a registered medical practitioner, or from a person having authority to sell it, or was deposited there without his knowledge or consent. The burden of proof is on the accused and section 20 sets no quantity threshold. Possession for supply and trafficking: the Act's text states no separate offence of possession for supply or of trafficking for Part III drugs. Sale and distribution: these are matters for rules the Minister may make under section 15(1)(b), and the only rules located are the 2025 methylamphetamine rules, which apply to methylamphetamine alone, so a sale offence for oxycodone is not verified beyond the general offence in section 39(1)(a) of contravening the Act or a rule under it. Import and export are two separate offences: section 14 prohibits them except in accordance with sections 22 to 30, section 3 limits entry and exit to an approved port, and a person exporting in contravention is also liable under section 35(2) to forfeit treble the value of the goods or 2,000 penalty units, at the option of the Comptroller of Customs and Excise. Manufacture: section 15(1)(a) lets rules prohibit manufacture except on licensed premises, and the Act's text states no manufacture offence itself. Cultivation: the instruments read state no cultivation offence for oxycodone; the plant offences in sections 7 and 8 concern the opium poppy, Indian hemp and coca leaf plants only. Use or consumption: the instruments read state no separate offence of use for Part III drugs, so possession under section 20 is the exposure. Administrative offences: section 39(1)(b) and (c) cover breach of licence conditions and false statements to obtain a licence or authority. Penalty: no penalty is otherwise prescribed, so section 39(2) applies to each offence. On conviction by the court sitting with assessors the fine is 100,000 penalty units, or imprisonment for ten years, or both; on summary conviction the fine is 5,000 penalty units, or imprisonment for six months, or both; and in every case all articles in respect of which the offence was committed are forfeited. Fine and imprisonment may be cumulative ('or to both such fine and imprisonment'). Section 39(4) gives attempting, soliciting and inciting the same punishment, and section 39(3) requires the consent of the Director of Public Prosecutions for proceedings under section 39(1)(a). The Act's drug provisions read state no death penalty. The Act does not state the value of a penalty unit and none is converted here.
If prescribed / medical: The medical route is in the Dangerous Drugs Act itself. Section 15(1)(c) lets the Minister make rules regulating the issue by medical practitioners of prescriptions containing a Part III drug and the dispensing of them, and section 15(2) requires the rules to authorise a pharmaceutical chemist or chemist and druggist to retail, dispense or compound such drugs in the ordinary course of business. Section 19 limits withdrawal from the store to a registered medical practitioner, licensed pharmacist, registered dentist, qualified veterinary surgeon, a hospital attendant approved at a plantation hospital, or a person approved for recognised Mission medical work. Section 20 lets a person found with the drug prove that it was obtained in accordance with the prescription of a registered medical practitioner. Section 39(3) bars imprisonment without the option of a fine, and caps the fine at 100 penalty units, for an inadvertent breach of the rules on keeping books or on prescriptions. Rules under section 15 other than the 2025 methylamphetamine rules were not located, so detailed prescription rules for oxycodone are not verified. The Pharmacy and Poisons Act (Cap. 105, reprint as in force 5 February 2024) also speaks to prescriptions for these drugs in its own text. Section 36(4) reads 'A prescription which does not comply with the provisions of this section shall not be accepted by any pharmacist as authority for the sale or supply of any medicine or drug'. Section 37(2) reads that every prescription 'containing any of the drugs to which any Act as to the sale of dangerous drugs, for the time being in force, relates, shall be retained in the custody of the pharmacist dispensing the same for a period of two years and filed in the pharmacy'. Section 38(c) provides that a pharmacist shall not 'permit any person, other than a registered pharmacist, to dispense or compound any prescription or supply any medicine or drugs containing any of the dangerous drugs to which subsection (2) of section 37 relates'. The Fourth Schedule to the Poisons Rules lists 'Oxycodone' with no exception (printed page 3035), so no strength or preparation is shown to be sold without a prescription. Rule 11(1) of the Poisons Rules (printed page 3004) reads 'It shall not be lawful to sell any poison included in the Fourth Schedule to these Rules except on and in accordance with the prescription given by a registered medical practitioner, registered dentist or a qualified veterinary surgeon in the form provided by this rule'. Rule 11(2) applies it to a sale even where the sale is exempted by section 57 of the Act, but not to a sale exempted by section 58 (wholesale dealing, and sales to a practitioner for his profession). Under rule 11(3) a prescription must be in writing, signed with the usual signature and dated, give the prescriber's address, give the name and address of the person treated (or of the person to whom the medicine is delivered, if given by a veterinary surgeon), and indicate the total amount to be supplied and the dose to be taken. Under rule 11(4) it may not be dispensed more than once unless the prescriber states that it may, the dispenser must note the seller's name, address and date on it, and it must be kept on the premises for two years. Section 2 of the Act reads 'poison includes the several substances mentioned in the poisons list in Schedule B', and rule 2(1) of the Poisons Rules (printed pages 3000 and 3001) defines 'poisons list' as 'the Poisons List contained in Schedule B of the Act'. Rule 11 is a sale rule under the pharmacy law and is separate from drug control under the Dangerous Drugs Act. The Poisons Rules were read as printed in the 1996 Revised Edition with margin notes amended to LN 63 of 1988; whether they were amended later or are still in force is not established, and the 2024 reprint of the Act does not print them.
Documentation: Importing oxycodone as a Part III drug requires an import authorisation in Form C granted by the Permanent Secretary, Ministry of Health and Medical Services under section 26, and section 28 provides that no dangerous drug shall be imported unless the person to whom it is consigned holds a valid and subsisting import authorisation. Section 29 requires an export authorisation or diversion certificate from a country party to the Convention to accompany the drug, and section 31 sets the transit conditions. Section 3 limits import and export to a port approved by notice; the notice printed at page 2821 of the 1996 edition (LN 41 of 1968, dated 24 September 1968) approves Honiara port and Henderson aerodrome, and later notices were not read. The only quantity exemption in the transit rules is section 31(5), for quantities that bona fide form part of the medical stores of a ship or aircraft. The sections read state no exemption for a traveller's personal supply, so none is established, and the Convention as defined in section 2 names only the 1912, 1925 and 1931 instruments. Under the Pharmacy and Poisons Act section 52(1) forbids importing 'any poison' except under a licence issued by the Board, with a proviso for qualified practitioners, registered pharmacists, veterinary surgeons and dentists importing for bona fide treatment; the proviso does not mention a traveller. The Customs and Excise Act was not read. A Dangerous Drugs (Amendment) Bill 2025 is reported as before Parliament; it was not read, and a Bill is not law.

Oxycodone in Solomon Islands, full detail →

PCP

Legal status: Controlled. Phencyclidine (PCP) is named in the schedule to the proclamation of 21 September 1987 (LN 101 of 1987) that applies Part III of the Dangerous Drugs Act (Cap. 98, reprint as in force 1 October 2009) under section 13(2): paragraph 1, printed page 2822, lists 'Phencyclidine', read from the page image. Paragraph 2 of the 1987 schedule extends Part III to 'Any stereoisomeric form of a substance specified in paragraph 1 not being dextromethorphan or dextrorphan', paragraph 3 to 'Any ester or ether' of such a substance, and paragraph 4 to 'Any salt'. Paragraph 5 reaches 'Any preparations or other product containing a substance' of paragraphs 1 to 4 'not being a preparation specified in Schedule 1'; no Schedule 1 appears in the pages read, so which preparations stand outside the control is not established. LN 6 of 1988 paragraphs (d) and (h) (printed page 2824) refer instead to 'the Schedule to the Proclamation referred to in paragraph (a)', so 'Schedule 1' in LN 101 paragraphs 5 and 9 may mean the paragraph 1 list of that Schedule; no instrument read states that reading. Phencyclidine is a single compound with its own entry; ketamine is a separate substance that is not named in the proclamations and is not the answer here. Phencyclidine is also printed in the Fourth Schedule to the Poisons Rules as 'Phencyclidine' and 'Phencyclidine Hydrochloride' (page 3036), which is a sale restriction and does not change the drug control above. The named entry governs.
Consequences if caught: Phencyclidine as a Part III drug through the proclamations. Personal possession: section 20 makes it an offence against the Act when a Part III drug is found in a person's possession or kept in any place other than the appointed store, unless he can prove that it was obtained under the authority of the Act, or in accordance with the prescription of a registered medical practitioner, or from a person having authority to sell it, or was deposited there without his knowledge or consent. The burden of proof is on the accused and section 20 sets no quantity threshold. Possession for supply and trafficking: the Act's text states no separate offence of possession for supply or of trafficking for Part III drugs. Sale and distribution: these are matters for rules the Minister may make under section 15(1)(b), and the only rules located are the 2025 methylamphetamine rules, which apply to methylamphetamine alone, so a sale offence for phencyclidine is not verified beyond the general offence in section 39(1)(a) of contravening the Act or a rule under it. Import and export are two separate offences: section 14 prohibits them except in accordance with sections 22 to 30, section 3 limits entry and exit to an approved port, and a person exporting in contravention is also liable under section 35(2) to forfeit treble the value of the goods or 2,000 penalty units, at the option of the Comptroller of Customs and Excise. Manufacture: section 15(1)(a) lets rules prohibit manufacture except on licensed premises, and the Act's text states no manufacture offence itself. Cultivation: the instruments read state no cultivation offence for phencyclidine; the plant offences in sections 7 and 8 concern the opium poppy, Indian hemp and coca leaf plants only. Use or consumption: the instruments read state no separate offence of use for Part III drugs, so possession under section 20 is the exposure. Administrative offences: section 39(1)(b) and (c) cover breach of licence conditions and false statements to obtain a licence or authority. Penalty: no penalty is otherwise prescribed, so section 39(2) applies to each offence. On conviction by the court sitting with assessors the fine is 100,000 penalty units, or imprisonment for ten years, or both; on summary conviction the fine is 5,000 penalty units, or imprisonment for six months, or both; and in every case all articles in respect of which the offence was committed are forfeited. Fine and imprisonment may be cumulative ('or to both such fine and imprisonment'). Section 39(4) gives attempting, soliciting and inciting the same punishment, and section 39(3) requires the consent of the Director of Public Prosecutions for proceedings under section 39(1)(a). The Act's drug provisions read state no death penalty. The Act does not state the value of a penalty unit and none is converted here.
If prescribed / medical: The medical route is in the Dangerous Drugs Act itself. Section 15(1)(c) lets the Minister make rules regulating the issue by medical practitioners of prescriptions containing a Part III drug and the dispensing of them, and section 15(2) requires the rules to authorise a pharmaceutical chemist or chemist and druggist to retail, dispense or compound such drugs in the ordinary course of business. Section 19 limits withdrawal from the store to a registered medical practitioner, licensed pharmacist, registered dentist, qualified veterinary surgeon, a hospital attendant approved at a plantation hospital, or a person approved for recognised Mission medical work. Section 20 lets a person found with the drug prove that it was obtained in accordance with the prescription of a registered medical practitioner. Section 39(3) bars imprisonment without the option of a fine, and caps the fine at 100 penalty units, for an inadvertent breach of the rules on keeping books or on prescriptions. Rules under section 15 other than the 2025 methylamphetamine rules were not located, so detailed prescription rules for phencyclidine are not verified. The Pharmacy and Poisons Act (Cap. 105, reprint as in force 5 February 2024) also speaks to prescriptions for these drugs in its own text. Section 36(4) reads 'A prescription which does not comply with the provisions of this section shall not be accepted by any pharmacist as authority for the sale or supply of any medicine or drug'. Section 37(2) reads that every prescription 'containing any of the drugs to which any Act as to the sale of dangerous drugs, for the time being in force, relates, shall be retained in the custody of the pharmacist dispensing the same for a period of two years and filed in the pharmacy'. Section 38(c) provides that a pharmacist shall not 'permit any person, other than a registered pharmacist, to dispense or compound any prescription or supply any medicine or drugs containing any of the dangerous drugs to which subsection (2) of section 37 relates'. The Fourth Schedule to the Poisons Rules lists 'Phencyclidine' and 'Phencyclidine Hydrochloride' with no exception (printed page 3036). Rule 11(1) of the Poisons Rules (printed page 3004) reads 'It shall not be lawful to sell any poison included in the Fourth Schedule to these Rules except on and in accordance with the prescription given by a registered medical practitioner, registered dentist or a qualified veterinary surgeon in the form provided by this rule'. Rule 11(2) applies it to a sale even where the sale is exempted by section 57 of the Act, but not to a sale exempted by section 58 (wholesale dealing, and sales to a practitioner for his profession). Under rule 11(3) a prescription must be in writing, signed with the usual signature and dated, give the prescriber's address, give the name and address of the person treated (or of the person to whom the medicine is delivered, if given by a veterinary surgeon), and indicate the total amount to be supplied and the dose to be taken. Under rule 11(4) it may not be dispensed more than once unless the prescriber states that it may, the dispenser must note the seller's name, address and date on it, and it must be kept on the premises for two years. Section 2 of the Act reads 'poison includes the several substances mentioned in the poisons list in Schedule B', and rule 2(1) of the Poisons Rules (printed pages 3000 and 3001) defines 'poisons list' as 'the Poisons List contained in Schedule B of the Act'. Rule 11 is a sale rule under the pharmacy law and is separate from drug control under the Dangerous Drugs Act. The Poisons Rules were read as printed in the 1996 Revised Edition with margin notes amended to LN 63 of 1988; whether they were amended later or are still in force is not established, and the 2024 reprint of the Act does not print them.
Documentation: Importing phencyclidine as a Part III drug requires an import authorisation in Form C granted by the Permanent Secretary, Ministry of Health and Medical Services under section 26, and section 28 provides that no dangerous drug shall be imported unless the person to whom it is consigned holds a valid and subsisting import authorisation. Section 29 requires an export authorisation or diversion certificate from a country party to the Convention to accompany the drug, and section 31 sets the transit conditions. Section 3 limits import and export to a port approved by notice; the notice printed at page 2821 of the 1996 edition (LN 41 of 1968, dated 24 September 1968) approves Honiara port and Henderson aerodrome, and later notices were not read. The only quantity exemption in the transit rules is section 31(5), for quantities that bona fide form part of the medical stores of a ship or aircraft. The sections read state no exemption for a traveller's personal supply, so none is established, and the Convention as defined in section 2 names only the 1912, 1925 and 1931 instruments. Under the Pharmacy and Poisons Act section 52(1) forbids importing 'any poison' except under a licence issued by the Board, with a proviso for qualified practitioners, registered pharmacists, veterinary surgeons and dentists importing for bona fide treatment; the proviso does not mention a traveller. The Customs and Excise Act was not read. A Dangerous Drugs (Amendment) Bill 2025 is reported as before Parliament; it was not read, and a Bill is not law.

PCP in Solomon Islands, full detail →

Scopolamine (Devil's Breath)

Legal status: Restricted as a poison, with sale by or under the supervision of a registered pharmacist. The instruments read never use the word scopolamine; they name hyoscine. The two names are one compound according to a chemical record and not according to any law read: the US National Library of Medicine MeSH concept M0553271 (descriptor D012601, Scopolamine) lists Hyoscine (term T037328) and Scopolamine (term T037329) as terms. Hyoscine is listed in Schedule B Part I (the Poisons List) of the Pharmacy and Poisons Act (Cap. 105), reprint as in force at 5 February 2024, among the alkaloids as 'Hyoscine.' Section 2 defines 'poison' as including 'the several substances mentioned in the poisons list in Schedule B', and section 56(1)(a) allows a Part I poison to be sold only by an authorised seller of poisons, on registered premises, by or under the supervision of a registered pharmacist. The Poisons Rules in the 1996 Revised Edition (margin notes to LN 63 of 1988) also list 'Hyoscine, except substances containing less than 0.15 per cent of hyoscine' in the First Schedule (printed page 3013) and 'Hyoscine; but if:' and 'Hyoscine Hydrobromide; but if:' in the Fourth Schedule (printed page 3029), each with printed exceptions for low strength internal preparations, inhalers and external preparations; that prescription rule is described in the prescription field, where its current force is stated as not established. Related entries are separate: 'Hyoscine Methobromide', 'Hyoscine Methonitrate', 'Hyoscine Butylbromide' (printed with a misspelling of the first word) and the 'Hyoscyamine' entries (pages 3029 to 3031) are printed as separate entries, and no instrument read states them to be the same compound as hyoscine, and 'Solanaceous alkaloids not otherwise included in this List' is a Part I class entry. This is a sale restriction under the pharmacy law. It is not drug control: hyoscine is not named in either proclamation list read, and because the Dangerous Drugs Act control is delegated and later proclamations were not all read, that is not a finding that it is outside that Act. Datura and other plant sources were searched by name and are not in any instrument held; no law of another country is imported. The Poisons Rules were read as printed in the 1996 Revised Edition with margin notes amended to LN 63 of 1988; whether they were amended later or are still in force is not established, and the 2024 reprint of the Act does not print them. A Dangerous Drugs (Amendment) Bill 2025 is reported as before Parliament; it was not read, and a Bill is not law. The list that carries this entry can move and the text read may be out of date: under section 52(3) and (4) of the Pharmacy and Poisons Act the Minister may by order add an article to the Poisons List, effective three months after Gazette publication, and the reprint read is as in force at 5 February 2024, incorporating amendments only up to the Legislation Amendment, Repeal and Validation Act 2023 (No. 17 of 2023); this text does not rule out a later order or amendment. The Dangerous Drugs Act lists can move as well: under section 13(2) the Minister may by proclamation apply Part III to any other drug, the reprint read is as in force at 1 October 2009, incorporating amendments only up to Act No. 14 of 2009; this text does not rule out a later proclamation or amendment.
Consequences if caught: Possession and use: the instruments read state no offence of possession or use of hyoscine as such; rule 11 and the Poisons List concern sale. Possession is therefore not shown to be an offence, which is a gap in what was read and not a finding that it is lawful. Sale: hyoscine is a Part I poison, so section 56(1)(a) of the Act forbids sale unless the seller is an authorised seller of poisons, the sale is on registered premises and it is effected by or under the supervision of a registered pharmacist; a poisons licence cannot cover Part I poisons (section 54(c)); section 56(2)(a) requires the buyer to be certified or known to the seller and bars sale or delivery to a person under twenty-one years; and section 56(2)(b) requires an entry in the Poisons Book signed by the purchaser. Penalty: section 52(5) gives a penalty of 5,000 penalty units, and for a continuing offence a further 300 penalty units a day after conviction, for acting in contravention of section 52, which forbids selling or dealing in a Poisons List article except in the manner the Act prescribes. For a breach of section 56 or of rule 11 with no specific penalty stated, section 62(1) gives not more than 3,000 penalty units and a further 600 a day. Which of the two figures governs a particular sale is not settled by the pages read. The Act does not state the value of a penalty unit and none is converted here. Import: section 52(1) forbids importing any poison except under a Board licence, and section 49(3) penalises importing for retail sale a drug or medicine the importer is not licensed to sell. Manufacture, cultivation and export: the instruments read state no offence for hyoscine. The drug provisions read state no death penalty, and the Dangerous Drugs Act penalty in section 39(2) is not shown to apply.
If prescribed / medical: This is the medicines route and the pharmacy law is where it lives. The Fourth Schedule entries are on printed pages 3029 and 3030. Rule 11(1) of the Poisons Rules (printed page 3004) reads 'It shall not be lawful to sell any poison included in the Fourth Schedule to these Rules except on and in accordance with the prescription given by a registered medical practitioner, registered dentist or a qualified veterinary surgeon in the form provided by this rule'. Rule 11(2) applies it to a sale even where the sale is exempted by section 57 of the Act, but not to a sale exempted by section 58 (wholesale dealing, and sales to a practitioner for his profession). Under rule 11(3) a prescription must be in writing, signed with the usual signature and dated, give the prescriber's address, give the name and address of the person treated (or of the person to whom the medicine is delivered, if given by a veterinary surgeon), and indicate the total amount to be supplied and the dose to be taken. Under rule 11(4) it may not be dispensed more than once unless the prescriber states that it may, the dispenser must note the seller's name, address and date on it, and it must be kept on the premises for two years. Section 39 of the Act lets a medical practitioner, qualified veterinary surgeon or qualified dentist dispense or compound medicine for patients without becoming a registered pharmacist if a true record is kept in the prescription book, and section 57 exempts a medicine supplied or dispensed by a practitioner or registered pharmacist from the poison sale rules, but rule 11(2) applies the prescription requirement notwithstanding section 57. The exceptions in the Fourth Schedule entries refer to 'Schedule 1', which the pages read do not define, and 'ms', 'md' and 'mdd' are not defined either, so which low strength or external preparations avoid prescription only sale is not established. Section 2 of the Act reads 'poison includes the several substances mentioned in the poisons list in Schedule B', and rule 2(1) of the Poisons Rules (printed pages 3000 and 3001) defines 'poisons list' as 'the Poisons List contained in Schedule B of the Act'. Rule 11 is a sale rule under the pharmacy law and is separate from drug control under the Dangerous Drugs Act. Whether these Rules are still in force is not established: the copy read is the 1996 Revised Edition (margin notes to LN 63 of 1988), the 2024 reprint of the Act keeps the rule making power in section 61 but does not print the Rules, its endnotes record repeals of sections 16 to 26, 28 to 32 and 35 by Act No. 5 of 1997 and amendments in 2009 and 2023, and nothing read states that the Rules were amended or revoked. The Part I entry 'Hyoscine.' in the 2024 reprint of the Act is what the verdict in the status field rests on.
Documentation: No traveller or personal import permit rule for hyoscine was found. Section 52(1) of the Pharmacy and Poisons Act forbids importing any poison except under a licence issued by the Board, with a proviso for qualified medical practitioners, registered pharmacists, qualified veterinary surgeons and qualified dentists importing for bona fide treatment; the proviso does not mention a traveller. Section 49 (importing for retail sale) and section 51 (the Under Secretary (Health) may certify to the Comptroller of Customs and Excise that a drug brought in is or is likely to be injurious, with the same proviso for practitioners) were read, and neither addresses a traveller carrying a personal supply. The import authorisation scheme of the Dangerous Drugs Act applies only to dangerous drugs, and hyoscine is not shown to be one. The Customs and Excise Act was not read. The position of a person carrying it into Solomon Islands is not established.

Dangerous Drugs Act (Cap. 98), reprint as in force 1 October 2009, sections 2, 3, 4 to 8, 11 to 15, 19 to 21, 26 to 31, 35 and 39 · attorneygenerals.gov.sb · Proclamations LN 101 of 1987 and LN 6 of 1988 applying Part III, as printed in the 1996 Revised Edition, Cap. 98 subsidiary legislation, printed pages 2821 to 2824 · solomon-islands.tradeportal.org · Pharmacy and Poisons Act (Cap. 105), reprint as in force 5 February 2024, sections 44 to 62 and Schedule B Poisons List · attorneygenerals.gov.sb · Poisons Rules under the Pharmacy and Poisons Act (Cap. 105), 1996 Revised Edition, printed pages 3000 to 3043, rules 2 and 11 and the First and Fourth Schedules · solomon-islands.tradeportal.org · Chemical identity source, cited as an identity record and not as law: NLM MeSH term T037328, Hyoscine, in concept M0553271 (descriptor D012601, Scopolamine) · id.nlm.nih.gov · NLM MeSH term T037329, Scopolamine, in the same concept · id.nlm.nih.gov · Updated October 7, 2026

Scopolamine (Devil's Breath) in Solomon Islands, full detail →

Tobacco

Legal status: Legal, with limits. Tobacco is regulated by the Tobacco Control Act 2010 (No. 2 of 2010), reprint as in force 5 February 2024, which commenced on 31 May 2012 and was amended only by Act No. 17 of 2023 (sections 10 and 16). It regulates labelling, distribution, sale, advertisement and smoking of tobacco products, and does not prohibit tobacco. Section 2 defines 'tobacco' as 'any preparation of dried leaves of the nicotiana tabacum plant of the nightshade family' and 'tobacco product' as 'any product from tobacco whether or not manufactured and intended for use by smoking, inhaling, mastication, orally taking by mouth or administration through the skin, and includes nasal or oral snuff or any product containing tobacco'. The limits the Act sets are: no sale, gift or supply to a child, defined as a person under eighteen (section 13); a licence from the Permanent Secretary to manufacture, sell, distribute, import or export any tobacco product (section 15); sale of cigarettes only in unbroken packages (section 12); no vending machines (section 14); health warnings on packages (section 9); no advertisement (section 4); and smoking bans in indoor parts of workplaces, schools, hospitals and health clinics, public transport and areas the Minister declares smoke-free (sections 19 to 22). The Poisons Rules carve tobacco out of the poison rules: Group II of the Third Schedule (printed page 3017) lists the poison 'Nicotine.' against the article 'Tobacco.', and rule 10(b) provides that nothing in Part VI of the Pharmacy and Poisons Act or the Rules applies to it. Tobacco is not named in the Dangerous Drugs Act or the proclamations read. A notice in Gazette No. 158 of 5 November 2025, made under section 28(1) of the Tobacco Control Act, appoints authorised officers, listed in the gazette copy as numbers 1 to 107. The regulations the Act refers to (warnings, toxic constituents) were not located, and the Liquor Act text mentions tobacco in its licence provisions and was not relied on. The Poisons Rules were read as printed in the 1996 Revised Edition with margin notes amended to LN 63 of 1988; whether they were amended later or are still in force is not established, and the 2024 reprint of the Act does not print them. The Dangerous Drugs Act lists can move as well: under section 13(2) the Minister may by proclamation apply Part III to any other drug, the reprint read is as in force at 1 October 2009, incorporating amendments only up to Act No. 14 of 2009; this text does not rule out a later proclamation or amendment.
Consequences if caught: Personal possession and use: the Act states no offence of possession of tobacco by an adult and no offence of smoking in private. Smoking is an offence in the places the Act lists: section 19(5) (workplaces and declared smoke-free areas), section 20(3) (schools, including grounds), section 21(3) (hospitals and health clinics, including outdoor areas) and section 22(6) (public transport and waiting rooms). Sale: section 13(1) says 'No person shall sell, give or in any way provide any tobacco product to a child', section 13(3) removes the defence of believing the buyer was over eighteen unless the accused took all reasonable steps to ascertain the age, and sections 12 and 14 and 9 set the pack, machine and warning rules. Trafficking, import, export and manufacture: section 15(1) forbids manufacturing, selling, distributing, importing or exporting any tobacco product without a licence, which covers each of those as an offence under section 15(7); the Act states no separate offence of possession for supply. Cultivation: the Act states no offence for growing tobacco. Penalty: section 37 says a person convicted of an offence under the Act is liable, for an individual, for a first offence to a fine not exceeding 20,000 penalty units or imprisonment not exceeding two years, and for a second or later offence to a fine not exceeding 50,000 penalty units or imprisonment not exceeding four years; the wording is 'or', so the fine and imprisonment are alternatives. For a body corporate the first offence fine is not more than 500,000 penalty units and a later offence not more than 1,000,000. Section 38 makes officers of a body corporate liable unless they prove no consent or connivance and due diligence. Orders on conviction: section 34(1) provides that on a conviction under section 4 the court, in addition to any penalty, orders that the advertisement be removed, obscured or destroyed by an authorised officer and that the convicted person pay the reasonable costs; section 34(2) provides that on a conviction under section 9, 11, 12, 15 or 17 the court may order the tobacco product to be confiscated, forfeited to the Crown and destroyed by an authorised officer, with the reasonable costs payable by the convicted person. The Act does not state the value of a penalty unit and none is converted here. The Act and the drug provisions read state no death penalty, and the Dangerous Drugs Act does not apply to tobacco on the pages read.
If prescribed / medical: No prescription route applies to tobacco as a consumer product, and none is stated in the Tobacco Control Act. Under the Pharmacy and Poisons Act the poison rules do not apply to tobacco (rule 10(b) with Group II of the Third Schedule). A prescription or medicine route for nicotine products other than tobacco is dealt with in the nicotine answer, and the Fourth Schedule to the Poisons Rules does not list tobacco or nicotine.
Documentation: Importing tobacco products needs a licence: section 15(1) says 'No person shall manufacture, sell, distribute, import or export or cause to be manufactured, sold, distributed, imported or exported any tobacco product except with a licence issued under this section', and section 15(6) says a licence under any other law does not authorise it. The Act states no personal allowance for a traveller, so none is established, and the Customs and Excise Act, which may set allowances, was not read. Section 9(7) requires imported tobacco products to carry a statement that they are intended to be sold in Solomon Islands, and section 11 prohibits import of products whose packaging is false or misleading. Whether duty or an allowance applies to a person carrying cigarettes into Solomon Islands is not established.

Tobacco Control Act 2010 (No. 2 of 2010), reprint as in force 5 February 2024, sections 2, 4 to 15, 19 to 22, 34 and 37 · attorneygenerals.gov.sb · Poisons Rules under the Pharmacy and Poisons Act (Cap. 105), 1996 Revised Edition, printed pages 3000 to 3043, rule 10 and the Third (Group II) and Fourth Schedules · solomon-islands.tradeportal.org · Pharmacy and Poisons Act (Cap. 105), reprint as in force 5 February 2024, sections 44 to 62 and Schedule B Poisons List · attorneygenerals.gov.sb · Updated October 7, 2026

Tobacco in Solomon Islands, full detail →

Not individually verified

64 substances are not individually verified for Solomon Islands

For these the governing national drug law is cited, but we have not verified that the substance specifically is scheduled under it. Treat them as unanswered, not as legal. Confirm with Solomon Islands’s drug authority or your embassy.

Substance	What we found
1P-LSD	Not confirmed. No entry for 1P-LSD was found in the instruments read. Searched: the Dangerous Drugs Act (Cap. 98)...
2-FDCK	Not confirmed. No entry for 2-FDCK was found in the instruments read. Searched: the Dangerous Drugs Act (Cap. 98)...
25I-NBOMe	Not confirmed. No entry for 25I-NBOMe was found in the instruments read. Searched: the Dangerous Drugs Act (Cap. 98)...
2C-B	Not confirmed. No entry for 2C-B was found in the instruments read. Searched: the Dangerous Drugs Act (Cap. 98)...
2C-E	Not confirmed. No entry for 2C-E was found in the instruments read. Searched: the Dangerous Drugs Act (Cap. 98)...
2C-I	Not confirmed. No entry for 2C-I was found in the instruments read. Searched: the Dangerous Drugs Act (Cap. 98)...
2C-T-7	Not confirmed. No entry for 2C-T-7 was found in the instruments read. Searched: the Dangerous Drugs Act (Cap. 98)...
3-MMC	Not confirmed. No entry for 3-MMC was found in the instruments read. Searched: the Dangerous Drugs Act (Cap. 98)...
4-AcO-DMT	Not confirmed. No entry for 4-AcO-DMT was found in the instruments read. Searched: the Dangerous Drugs Act (Cap. 98)...
4-HO-MET	Not confirmed. No entry for 4-HO-MET was found in the instruments read. Searched: the Dangerous Drugs Act (Cap. 98)...
5-MeO-DMT (Bufo / Toad)	Not confirmed. No entry for 5-MeO-DMT was found in the instruments read. Searched: the Dangerous Drugs Act (Cap. 98)...
6-APB	Not confirmed. No entry for 6-APB was found in the instruments read. Searched: the Dangerous Drugs Act (Cap. 98)...
7-Hydroxymitragynine (7-OH)	Not confirmed. No entry for 7-hydroxymitragynine was found in the instruments read. Searched: the Dangerous Drugs...
Amanita muscaria	Not confirmed. No entry for Amanita muscaria and its constituents was found in the instruments read. Searched: the...
Ayahuasca	Not confirmed. No entry for ayahuasca and its constituents was found in the instruments read. Searched: the...
Benzodiazepines	Not confirmed. The Poisons Rules under the Pharmacy and Poisons Act (Cap. 105) in the 1996 Revised Edition print...
Caffeine	Not confirmed. No entry for caffeine was found in the instruments read. Searched: the Dangerous Drugs Act (Cap. 98)...
Cannabinol	Not confirmed. No entry for cannabinol was found in the instruments read. Searched: the Dangerous Drugs Act (Cap....
Cathinone	Not confirmed. No entry for cathinone and khat was found in the instruments read. Searched: the Dangerous Drugs Act...
CBD	Not confirmed. No entry for cannabidiol (CBD) was found in the instruments read. Searched: the Dangerous Drugs Act...
Clonazepam	Not confirmed. The Poisons Rules under the Pharmacy and Poisons Act (Cap. 105) in the 1996 Revised Edition print...
Delta-8-THC	Not confirmed. No entry for delta-8-THC was found in the instruments read. Searched: the Dangerous Drugs Act (Cap....
Diazepam	Not confirmed. The Poisons Rules under the Pharmacy and Poisons Act (Cap. 105) in the 1996 Revised Edition print...
DMT	Not confirmed. No entry for DMT (N,N-dimethyltryptamine) was found in the instruments read. Searched: the Dangerous...
DOM	Not confirmed. No entry for DOM was found in the instruments read. Searched: the Dangerous Drugs Act (Cap. 98)...
DXM	Not confirmed. The Poisons Rules under the Pharmacy and Poisons Act (Cap. 105) in the 1996 Revised Edition print...
Ephedrine	Not confirmed. The Poisons Rules under the Pharmacy and Poisons Act (Cap. 105) in the 1996 Revised Edition print...
Etizolam	Not confirmed. No entry for etizolam was found in the instruments read. Searched: the Dangerous Drugs Act (Cap. 98)...
Gabapentin	Not confirmed. No entry for gabapentin was found in the instruments read. Searched: the Dangerous Drugs Act (Cap....
GBL	Not confirmed. No entry for GBL (gamma-butyrolactone) was found in the instruments read. Searched: the Dangerous...
GHB	Not confirmed. No entry for GHB (gamma-hydroxybutyrate) was found in the instruments read. Searched: the Dangerous...
HHC	Not confirmed. No entry for HHC (hexahydrocannabinol) was found in the instruments read. Searched: the Dangerous...
Ketamine	Not confirmed. The Poisons Rules under the Pharmacy and Poisons Act (Cap. 105) in the 1996 Revised Edition print...
Khat	Not confirmed. No entry for khat (the plant Catha edulis) and its constituents was found in the instruments read....
Kratom	Not confirmed. No entry for kratom (the plant Mitragyna speciosa) and its constituents was found in the instruments...
Lorazepam	Not confirmed. The Poisons Rules under the Pharmacy and Poisons Act (Cap. 105) in the 1996 Revised Edition print...
LSA (Morning Glory)	Not confirmed. No entry for LSA (lysergic acid amide) was found in the instruments read. Searched: the Dangerous...
LSD	Not confirmed. No entry for LSD (lysergide) was found in the instruments read. Searched: the Dangerous Drugs Act...
MDA	Not confirmed. No entry for MDA (3,4-methylenedioxyamphetamine) was found in the instruments read. Searched: the...
MDMA	Not confirmed. No entry for MDMA was found in the instruments read. Searched: the Dangerous Drugs Act (Cap. 98)...
MDPV	Not confirmed. No entry for MDPV was found in the instruments read. Searched: the Dangerous Drugs Act (Cap. 98)...
Memantine	Not confirmed. No entry for memantine was found in the instruments read. Searched: the Dangerous Drugs Act (Cap. 98)...
Mephedrone (4-MMC)	Not confirmed. No entry for mephedrone was found in the instruments read. Searched: the Dangerous Drugs Act (Cap....
Mescaline	Not confirmed. No entry for mescaline was found in the instruments read. Searched: the Dangerous Drugs Act (Cap. 98)...
Methylone	Not confirmed. No entry for methylone was found in the instruments read. Searched: the Dangerous Drugs Act (Cap. 98)...
Mitragynine	Not confirmed. No entry for mitragynine was found in the instruments read. Searched: the Dangerous Drugs Act (Cap....
Modafinil	Not confirmed. No entry for modafinil was found in the instruments read. Searched: the Dangerous Drugs Act (Cap. 98)...
MXE	Not confirmed. No entry for methoxetamine (MXE) was found in the instruments read. Searched: the Dangerous Drugs Act...
Nimetazepam	Not confirmed. No entry for nimetazepam was found in the instruments read. Searched: the Dangerous Drugs Act (Cap....
Nitrous Oxide	Not confirmed. No entry for nitrous oxide was found in the instruments read. Searched: the Dangerous Drugs Act (Cap....
Peyote	Not confirmed. No entry for peyote was found in the instruments read. Searched: the Dangerous Drugs Act (Cap. 98)...
Phenibut	Not confirmed. No entry for phenibut was found in the instruments read. Searched: the Dangerous Drugs Act (Cap. 98)...
Pink Cocaine / Tusi	Not confirmed. No instrument read names or defines pink cocaine, and the content of a product sold under that name...
Poppers	Not confirmed. Poppers is a class slug and no single verdict is given for the class; the amyl-nitrite answer carries...
Pregabalin	Not confirmed. No entry for pregabalin was found in the instruments read. Searched: the Dangerous Drugs Act (Cap....
Psilocybin	Not confirmed. No entry for psilocybin was found in the instruments read. Searched: the Dangerous Drugs Act (Cap....
Quetiapine	Not confirmed. No entry for quetiapine was found in the instruments read. Searched: the Dangerous Drugs Act (Cap....
Salvia divinorum	Not confirmed. No entry for Salvia divinorum was found in the instruments read. Searched: the Dangerous Drugs Act...
Synthetic Cannabinoids (K2 / Spice)	Not confirmed. No entry for the synthetic cannabinoids was found in the instruments read. Searched: the Dangerous...
THC-P	Not confirmed. No entry for THC-P was found in the instruments read. Searched: the Dangerous Drugs Act (Cap. 98)...
Tramadol	Not confirmed. No entry for tramadol was found in the instruments read. Searched: the Dangerous Drugs Act (Cap. 98)...
Xanax (Alprazolam)	Not confirmed. No entry for alprazolam was found in the instruments read. Searched: the Dangerous Drugs Act (Cap....
Xylazine	Not confirmed. The Poisons Rules under the Pharmacy and Poisons Act (Cap. 105) in the 1996 Revised Edition print...
Zolpidem	Not confirmed. No entry for zolpidem was found in the instruments read. Searched: the Dangerous Drugs Act (Cap. 98)...

Drug laws and enforcement change and vary by country. This is not legal advice. Always confirm with the destination’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.

Before you travel

Verify current rules with the destination country’s official drug authority and your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.

If you’re detained or arrested abroad

Contact your own country’s embassy or consulate in the destination immediately, not the destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →

← All countries Drug index